cancer_type	qtl_type	tag_SNP	LD	SNP_id	gene_id	gene_symbol	t-stat	p-value	beta	r	Traits	SNP_position	Gene_position
CESC	cis	rs75358501	0.636	rs2241347	MIMAT0014995	hsa-miR-3130-5p	-18.13	2.14e-45	-0.82	-0.78	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.636	rs2241347	MIMAT0014995_1	hsa-miR-3130-5p	-18.13	2.14e-45	-0.82	-0.78	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783246~206783266:+
CESC	cis	rs75358501	0.636	rs7576591	MIMAT0014995	hsa-miR-3130-5p	-17.56	1.29e-43	-0.82	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.636	rs7576591	MIMAT0014995_1	hsa-miR-3130-5p	-17.56	1.29e-43	-0.82	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783246~206783266:+
CESC	cis	rs75358501	0.636	rs2287628	MIMAT0014995	hsa-miR-3130-5p	-17.25	1.23e-42	-0.81	-0.76	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.636	rs2287628	MIMAT0014995_1	hsa-miR-3130-5p	-17.25	1.23e-42	-0.81	-0.76	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783246~206783266:+
CESC	cis	rs75358501	0.636	rs888621	MIMAT0014995	hsa-miR-3130-5p	17.02	7.06e-42	0.8	0.76	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.636	rs888621	MIMAT0014995_1	hsa-miR-3130-5p	17.02	7.06e-42	0.8	0.76	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783246~206783266:+
CESC	cis	rs75358501	0.688	rs2287629	MIMAT0014995	hsa-miR-3130-5p	16.9	1.67e-41	0.78	0.75	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.688	rs2287629	MIMAT0014995_1	hsa-miR-3130-5p	16.9	1.67e-41	0.78	0.75	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783246~206783266:+
CESC	cis	rs75358501	0.636	rs10199766	MIMAT0014995	hsa-miR-3130-5p	-15.81	5.03e-38	-0.79	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.636	rs10199766	MIMAT0014995_1	hsa-miR-3130-5p	-15.81	5.03e-38	-0.79	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783246~206783266:+
CESC	cis	rs75358501	0.636	rs13427002	MIMAT0014995	hsa-miR-3130-5p	-15.81	5.03e-38	-0.79	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.636	rs13427002	MIMAT0014995_1	hsa-miR-3130-5p	-15.81	5.03e-38	-0.79	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783246~206783266:+
CESC	cis	rs75358501	0.636	rs12471008	MIMAT0014995	hsa-miR-3130-5p	-15.7	1.16e-37	-0.79	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.636	rs12471008	MIMAT0014995_1	hsa-miR-3130-5p	-15.7	1.16e-37	-0.79	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783246~206783266:+
CESC	cis	rs75358501	0.636	rs768533	MIMAT0014995	hsa-miR-3130-5p	-15.7	1.16e-37	-0.79	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.636	rs768533	MIMAT0014995_1	hsa-miR-3130-5p	-15.7	1.16e-37	-0.79	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783246~206783266:+
CESC	cis	rs75358501	0.636	rs725980	MIMAT0014995	hsa-miR-3130-5p	-15.24	3.39e-36	-0.78	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.636	rs725980	MIMAT0014995_1	hsa-miR-3130-5p	-15.24	3.39e-36	-0.78	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783246~206783266:+
CESC	cis	rs75358501	0.584	rs11894165	MIMAT0014995	hsa-miR-3130-5p	-15.03	1.62e-35	-0.79	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.584	rs11894165	MIMAT0014995_1	hsa-miR-3130-5p	-15.03	1.62e-35	-0.79	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783246~206783266:+
CESC	cis	rs75358501	0.688	rs1862087	MIMAT0014995	hsa-miR-3130-5p	-15.03	1.62e-35	-0.79	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.688	rs1862087	MIMAT0014995_1	hsa-miR-3130-5p	-15.03	1.62e-35	-0.79	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783246~206783266:+
CESC	cis	rs75358501	0.636	rs11895370	MIMAT0014995	hsa-miR-3130-5p	-14.81	8.6e-35	-0.77	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.636	rs11895370	MIMAT0014995_1	hsa-miR-3130-5p	-14.81	8.6e-35	-0.77	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783246~206783266:+
CESC	cis	rs75358501	0.636	rs16838834	MIMAT0014995	hsa-miR-3130-5p	-13.45	2e-30	-0.75	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.636	rs16838834	MIMAT0014995_1	hsa-miR-3130-5p	-13.45	2e-30	-0.75	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783246~206783266:+
CESC	cis	rs75358501	0.688	rs28365797	MIMAT0014995	hsa-miR-3130-5p	-13.4	2.93e-30	-0.74	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.688	rs28365797	MIMAT0014995_1	hsa-miR-3130-5p	-13.4	2.93e-30	-0.74	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783246~206783266:+
CESC	cis	rs75358501	0.636	rs3815686	MIMAT0014995	hsa-miR-3130-5p	-13.36	3.85e-30	-0.75	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.636	rs3815686	MIMAT0014995_1	hsa-miR-3130-5p	-13.36	3.85e-30	-0.75	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783246~206783266:+
CESC	cis	rs75358501	0.636	rs10932164	MIMAT0014995	hsa-miR-3130-5p	-13.32	5.2e-30	-0.75	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.636	rs10932164	MIMAT0014995_1	hsa-miR-3130-5p	-13.32	5.2e-30	-0.75	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783246~206783266:+
CESC	cis	rs7255436	0.965	rs4044435	MIMAT0021017	hsa-miR-4999-5p	7.04	2.53e-11	0.5	0.43	HDL cholesterol;	chr19:8383293	chr19:8389340~8389360:-
CESC	cis	rs7255436	0.965	rs7254882	MIMAT0021017	hsa-miR-4999-5p	6.65	2.37e-10	0.48	0.41	HDL cholesterol;	chr19:8388938	chr19:8389340~8389360:-
CESC	cis	rs7255436	1	rs7255436	MIMAT0021017	hsa-miR-4999-5p	6.61	2.89e-10	0.48	0.41	HDL cholesterol;	chr19:8368312	chr19:8389340~8389360:-
CESC	cis	rs7255436	0.83	rs4350678	MIMAT0021017	hsa-miR-4999-5p	6.6	3.17e-10	0.47	0.41	HDL cholesterol;	chr19:8382482	chr19:8389340~8389360:-
CESC	cis	rs7255436	0.931	rs7249520	MIMAT0021017	hsa-miR-4999-5p	6.57	3.61e-10	0.48	0.41	HDL cholesterol;	chr19:8381172	chr19:8389340~8389360:-
CESC	cis	rs7255436	0.965	rs7249624	MIMAT0021017	hsa-miR-4999-5p	6.57	3.61e-10	0.48	0.41	HDL cholesterol;	chr19:8381251	chr19:8389340~8389360:-
CESC	cis	rs7255436	0.928	rs7250870	MIMAT0021017	hsa-miR-4999-5p	6.56	3.96e-10	0.47	0.41	HDL cholesterol;	chr19:8388798	chr19:8389340~8389360:-
CESC	cis	rs7255436	0.965	rs11668346	MIMAT0021017	hsa-miR-4999-5p	6.54	4.29e-10	0.47	0.41	HDL cholesterol;	chr19:8385970	chr19:8389340~8389360:-
CESC	cis	rs7255436	0.965	rs12981318	MIMAT0021017	hsa-miR-4999-5p	6.54	4.29e-10	0.47	0.41	HDL cholesterol;	chr19:8386546	chr19:8389340~8389360:-
CESC	cis	rs7255436	0.965	rs7351098	MIMAT0021017	hsa-miR-4999-5p	6.54	4.29e-10	0.47	0.41	HDL cholesterol;	chr19:8386787	chr19:8389340~8389360:-
CESC	cis	rs7255436	0.965	rs11666003	MIMAT0021017	hsa-miR-4999-5p	6.54	4.32e-10	0.47	0.4	HDL cholesterol;	chr19:8387218	chr19:8389340~8389360:-
CESC	cis	rs7255436	0.965	rs11666233	MIMAT0021017	hsa-miR-4999-5p	6.49	5.64e-10	0.47	0.4	HDL cholesterol;	chr19:8387161	chr19:8389340~8389360:-
CESC	cis	rs75358501	0.901	rs79499040	MIMAT0014995	hsa-miR-3130-5p	-6.14	3.81e-09	-0.58	-0.38	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.901	rs79499040	MIMAT0014995_1	hsa-miR-3130-5p	-6.14	3.81e-09	-0.58	-0.38	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783246~206783266:+
CESC	cis	rs1712517	0.524	rs4917384	MIMAT0005951	hsa-miR-1307-3p	6	8.34e-09	0.32	0.38	Migraine;	chr10:103236031	chr10:103394301~103394322:-
CESC	cis	rs4917385	1	rs4917385	MIMAT0005951	hsa-miR-1307-3p	5.98	9.02e-09	0.31	0.38	Systemic lupus erythematosus;	chr10:103243964	chr10:103394301~103394322:-
CESC	cis	rs1712517	0.524	rs1712509	MIMAT0005951	hsa-miR-1307-3p	-5.98	9.18e-09	-0.32	-0.38	Migraine;	chr10:103254113	chr10:103394301~103394322:-
CESC	cis	rs75358501	0.901	rs76270461	MIMAT0014995	hsa-miR-3130-5p	-5.95	1.04e-08	-0.56	-0.37	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.901	rs76270461	MIMAT0014995_1	hsa-miR-3130-5p	-5.95	1.04e-08	-0.56	-0.37	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783246~206783266:+
CESC	cis	rs6543140	0.964	rs6543136	MIMAT0019927	hsa-miR-4772-3p	-5.82	2.09e-08	-0.42	-0.37	Blood protein levels;	chr2:102449087	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs6543138	MIMAT0019927	hsa-miR-4772-3p	-5.71	3.69e-08	-0.41	-0.36	Blood protein levels;	chr2:102449672	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs918000	MIMAT0019927	hsa-miR-4772-3p	-5.71	3.69e-08	-0.41	-0.36	Blood protein levels;	chr2:102451402	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.927	rs917999	MIMAT0019927	hsa-miR-4772-3p	-5.71	3.69e-08	-0.41	-0.36	Blood protein levels;	chr2:102451409	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs6748390	MIMAT0019927	hsa-miR-4772-3p	-5.68	4.24e-08	-0.41	-0.36	Blood protein levels;	chr2:102445715	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs6736135	MIMAT0019927	hsa-miR-4772-3p	-5.66	4.67e-08	-0.4	-0.36	Blood protein levels;	chr2:102448464	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs2080288	MIMAT0019927	hsa-miR-4772-3p	-5.58	7.04e-08	-0.4	-0.35	Blood protein levels;	chr2:102405706	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs2141781	MIMAT0019927	hsa-miR-4772-3p	-5.55	8.11e-08	-0.39	-0.35	Blood protein levels;	chr2:102466446	chr2:102432336~102432357:+
CESC	cis	rs12712135	0.709	rs55664618	MIMAT0019927	hsa-miR-4772-3p	5.54	8.49e-08	0.33	0.35	Blood protein levels;	chr2:102399756	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs1474309	MIMAT0019926	hsa-miR-4772-5p	5.54	8.72e-08	0.77	0.35	Serum protein levels (sST2);	chr2:102474542	chr2:102432300~102432321:+
CESC	cis	rs6543140	0.964	rs1035126	MIMAT0019927	hsa-miR-4772-3p	-5.52	9.51e-08	-0.39	-0.35	Blood protein levels;	chr2:102403521	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs62154972	MIMAT0019927	hsa-miR-4772-3p	-5.48	1.15e-07	-0.39	-0.35	Blood protein levels;	chr2:102432278	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs10200081	MIMAT0019927	hsa-miR-4772-3p	-5.48	1.19e-07	-0.38	-0.35	Blood protein levels;	chr2:102475097	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs10196334	MIMAT0019927	hsa-miR-4772-3p	-5.47	1.21e-07	-0.38	-0.35	Blood protein levels;	chr2:102473582	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs11903551	MIMAT0019927	hsa-miR-4772-3p	-5.45	1.33e-07	-0.38	-0.35	Blood protein levels;	chr2:102467721	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs6543143	MIMAT0019927	hsa-miR-4772-3p	-5.45	1.33e-07	-0.38	-0.35	Blood protein levels;	chr2:102468960	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs13383602	MIMAT0019927	hsa-miR-4772-3p	-5.45	1.33e-07	-0.38	-0.35	Blood protein levels;	chr2:102469502	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs4851592	MIMAT0019927	hsa-miR-4772-3p	-5.45	1.33e-07	-0.38	-0.35	Blood protein levels;	chr2:102471181	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs10193485	MIMAT0019927	hsa-miR-4772-3p	-5.45	1.33e-07	-0.38	-0.35	Blood protein levels;	chr2:102473114	chr2:102432336~102432357:+
CESC	cis	rs1712517	0.873	rs7913461	MIMAT0005951	hsa-miR-1307-3p	-5.44	1.43e-07	-0.26	-0.35	Migraine;	chr10:103241568	chr10:103394301~103394322:-
CESC	cis	rs6543140	0.601	rs78178597	MIMAT0019927	hsa-miR-4772-3p	-5.44	1.43e-07	-0.42	-0.35	Blood protein levels;	chr2:102407136	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.601	rs6543135	MIMAT0019927	hsa-miR-4772-3p	-5.43	1.51e-07	-0.42	-0.35	Blood protein levels;	chr2:102445946	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs4851593	MIMAT0019927	hsa-miR-4772-3p	5.41	1.67e-07	0.38	0.34	Blood protein levels;	chr2:102472767	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.929	rs11465700	MIMAT0019927	hsa-miR-4772-3p	-5.4	1.76e-07	-0.39	-0.34	Blood protein levels;	chr2:102441208	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs4851010	MIMAT0019927	hsa-miR-4772-3p	5.39	1.81e-07	0.39	0.34	Blood protein levels;	chr2:102439667	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs2160202	MIMAT0019927	hsa-miR-4772-3p	5.39	1.86e-07	0.36	0.34	Serum protein levels (sST2);	chr2:102369694	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs1523206	MIMAT0019927	hsa-miR-4772-3p	-5.37	2.06e-07	-0.38	-0.34	Blood protein levels;	chr2:102453715	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs1523205	MIMAT0019927	hsa-miR-4772-3p	-5.37	2.06e-07	-0.38	-0.34	Blood protein levels;	chr2:102453716	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs3771171	MIMAT0019927	hsa-miR-4772-3p	5.36	2.16e-07	0.36	0.34	Serum protein levels (sST2);	chr2:102369490	chr2:102432336~102432357:+
CESC	cis	rs6841433	0.948	rs35736852	MIMAT0003242	hsa-miR-577	5.34	2.37e-07	0.53	0.34	Hemoglobin concentration;	chr4:114687255	chr4:114656774~114656794:+
CESC	cis	rs6543140	0.964	rs10169192	MIMAT0019927	hsa-miR-4772-3p	-5.32	2.53e-07	-0.37	-0.34	Blood protein levels;	chr2:102455751	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs11886793	MIMAT0019927	hsa-miR-4772-3p	-5.32	2.53e-07	-0.37	-0.34	Blood protein levels;	chr2:102455760	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs2310301	MIMAT0019927	hsa-miR-4772-3p	-5.32	2.53e-07	-0.37	-0.34	Blood protein levels;	chr2:102456475	chr2:102432336~102432357:+
CESC	cis	rs6543140	1	rs6543140	MIMAT0019927	hsa-miR-4772-3p	-5.32	2.53e-07	-0.37	-0.34	Blood protein levels;	chr2:102457814	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs13390895	MIMAT0019927	hsa-miR-4772-3p	-5.32	2.53e-07	-0.37	-0.34	Blood protein levels;	chr2:102459039	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.855	rs4851591	MIMAT0019927	hsa-miR-4772-3p	-5.32	2.53e-07	-0.37	-0.34	Blood protein levels;	chr2:102460963	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs7561351	MIMAT0019927	hsa-miR-4772-3p	-5.32	2.53e-07	-0.37	-0.34	Blood protein levels;	chr2:102461320	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs13393175	MIMAT0019927	hsa-miR-4772-3p	-5.32	2.53e-07	-0.37	-0.34	Blood protein levels;	chr2:102462389	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.865	rs6760275	MIMAT0019927	hsa-miR-4772-3p	-5.32	2.53e-07	-0.37	-0.34	Blood protein levels;	chr2:102463147	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs6734203	MIMAT0019927	hsa-miR-4772-3p	-5.32	2.53e-07	-0.37	-0.34	Blood protein levels;	chr2:102463606	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs6543142	MIMAT0019927	hsa-miR-4772-3p	-5.32	2.53e-07	-0.37	-0.34	Blood protein levels;	chr2:102465546	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.929	rs6742530	MIMAT0019927	hsa-miR-4772-3p	-5.32	2.53e-07	-0.37	-0.34	Blood protein levels;	chr2:102465820	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs3771172	MIMAT0019927	hsa-miR-4772-3p	5.3	2.8e-07	0.36	0.34	Serum protein levels (sST2);	chr2:102369352	chr2:102432336~102432357:+
CESC	cis	rs6841433	0.95	rs28696112	MIMAT0003242	hsa-miR-577	5.29	2.97e-07	0.52	0.34	Hemoglobin concentration;	chr4:114601833	chr4:114656774~114656794:+
CESC	cis	rs950880	0.71	rs67723747	MIMAT0019927	hsa-miR-4772-3p	5.29	2.97e-07	0.35	0.34	Serum protein levels (sST2);	chr2:102353347	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs56386507	MIMAT0019927	hsa-miR-4772-3p	5.29	2.97e-07	0.35	0.34	Serum protein levels (sST2);	chr2:102354705	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs4851578	MIMAT0019927	hsa-miR-4772-3p	-5.29	2.99e-07	-0.38	-0.34	Blood protein levels;	chr2:102412491	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs6761350	MIMAT0019927	hsa-miR-4772-3p	-5.29	2.99e-07	-0.38	-0.34	Blood protein levels;	chr2:102414316	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.929	rs7602207	MIMAT0019927	hsa-miR-4772-3p	-5.29	2.99e-07	-0.38	-0.34	Blood protein levels;	chr2:102415906	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs2160200	MIMAT0019927	hsa-miR-4772-3p	-5.29	2.99e-07	-0.38	-0.34	Blood protein levels;	chr2:102417503	chr2:102432336~102432357:+
CESC	cis	rs6841433	1	rs34115976	MIMAT0003242	hsa-miR-577	5.28	3.12e-07	0.52	0.34	Hemoglobin concentration;	chr4:114656841	chr4:114656774~114656794:+
CESC	cis	rs6841433	1	rs13133899	MIMAT0003242	hsa-miR-577	5.28	3.12e-07	0.52	0.34	Hemoglobin concentration;	chr4:114661153	chr4:114656774~114656794:+
CESC	cis	rs6543140	0.89	rs61122764	MIMAT0019927	hsa-miR-4772-3p	-5.28	3.14e-07	-0.38	-0.34	Blood protein levels;	chr2:102383060	chr2:102432336~102432357:+
CESC	cis	rs1712517	0.525	rs2271751	MIMAT0005951	hsa-miR-1307-3p	-5.25	3.6e-07	-0.28	-0.34	Migraine;	chr10:103415374	chr10:103394301~103394322:-
CESC	cis	rs6841433	0.904	rs4130705	MIMAT0003242	hsa-miR-577	5.24	3.81e-07	0.52	0.33	Hemoglobin concentration;	chr4:114609479	chr4:114656774~114656794:+
CESC	cis	rs950880	0.71	rs12469506	MIMAT0019927	hsa-miR-4772-3p	5.24	3.81e-07	0.35	0.33	Serum protein levels (sST2);	chr2:102349411	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs56258475	MIMAT0019927	hsa-miR-4772-3p	5.23	3.99e-07	0.34	0.33	Serum protein levels (sST2);	chr2:102382852	chr2:102432336~102432357:+
CESC	cis	rs6841433	1	rs7677294	MIMAT0003242	hsa-miR-577	5.23	4.04e-07	0.51	0.33	Hemoglobin concentration;	chr4:114633283	chr4:114656774~114656794:+
CESC	cis	rs6543140	0.964	rs6543144	MIMAT0019927	hsa-miR-4772-3p	-5.21	4.4e-07	-0.37	-0.33	Blood protein levels;	chr2:102476116	chr2:102432336~102432357:+
CESC	cis	rs950880	0.744	rs3771156	MIMAT0019927	hsa-miR-4772-3p	5.18	5.09e-07	0.34	0.33	Serum protein levels (sST2);	chr2:102420217	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs17027006	MIMAT0019927	hsa-miR-4772-3p	-5.18	5.14e-07	-0.35	-0.33	Serum protein levels (sST2);	chr2:102348872	chr2:102432336~102432357:+
CESC	cis	rs6841433	0.948	rs13135834	MIMAT0003242	hsa-miR-577	5.15	5.82e-07	0.51	0.33	Hemoglobin concentration;	chr4:114678835	chr4:114656774~114656794:+
CESC	cis	rs950880	0.71	rs2270298	MIMAT0019927	hsa-miR-4772-3p	5.14	6.22e-07	0.33	0.33	Serum protein levels (sST2);	chr2:102375619	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs17027037	MIMAT0019927	hsa-miR-4772-3p	5.14	6.22e-07	0.33	0.33	Serum protein levels (sST2);	chr2:102378424	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs2080289	MIMAT0019927	hsa-miR-4772-3p	5.14	6.22e-07	0.33	0.33	Serum protein levels (sST2);	chr2:102378560	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs3821203	MIMAT0019927	hsa-miR-4772-3p	5.14	6.22e-07	0.33	0.33	Serum protein levels (sST2);	chr2:102380412	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs3771162	MIMAT0019927	hsa-miR-4772-3p	5.14	6.22e-07	0.33	0.33	Serum protein levels (sST2);	chr2:102380714	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs11465633	MIMAT0019927	hsa-miR-4772-3p	5.14	6.22e-07	0.33	0.33	Serum protein levels (sST2);	chr2:102381273	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs1035130	MIMAT0019927	hsa-miR-4772-3p	5.14	6.22e-07	0.33	0.33	Serum protein levels (sST2);	chr2:102384942	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.601	rs7558013	MIMAT0019927	hsa-miR-4772-3p	-5.13	6.27e-07	-0.39	-0.33	Blood protein levels;	chr2:102376346	chr2:102432336~102432357:+
CESC	cis	rs75358501	0.636	rs12471008	MIMAT0014994	hsa-miR-3130-3p	5.12	6.73e-07	0.44	0.33	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783245~206783265:-
CESC	cis	rs75358501	0.636	rs12471008	MIMAT0014994_1	hsa-miR-3130-3p	5.12	6.73e-07	0.44	0.33	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783277~206783297:+
CESC	cis	rs75358501	0.636	rs768533	MIMAT0014994	hsa-miR-3130-3p	5.12	6.73e-07	0.44	0.33	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783245~206783265:-
CESC	cis	rs75358501	0.636	rs768533	MIMAT0014994_1	hsa-miR-3130-3p	5.12	6.73e-07	0.44	0.33	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783277~206783297:+
CESC	cis	rs950880	0.71	rs11683700	MIMAT0019927	hsa-miR-4772-3p	5.12	6.78e-07	0.34	0.33	Serum protein levels (sST2);	chr2:102380345	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs11693955	MIMAT0019927	hsa-miR-4772-3p	5.11	6.99e-07	0.33	0.33	Serum protein levels (sST2);	chr2:102412705	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs4851570	MIMAT0019927	hsa-miR-4772-3p	5.11	7.11e-07	0.33	0.33	Serum protein levels (sST2);	chr2:102389927	chr2:102432336~102432357:+
CESC	cis	rs6841433	1	rs10011293	MIMAT0003242	hsa-miR-577	5.1	7.3e-07	0.5	0.33	Hemoglobin concentration;	chr4:114656225	chr4:114656774~114656794:+
CESC	cis	rs6841433	1	rs28390138	MIMAT0003242	hsa-miR-577	5.1	7.31e-07	0.5	0.33	Hemoglobin concentration;	chr4:114687320	chr4:114656774~114656794:+
CESC	cis	rs1712517	0.525	rs11191667	MIMAT0005951	hsa-miR-1307-3p	-5.07	8.35e-07	-0.26	-0.32	Migraine;	chr10:103369141	chr10:103394301~103394322:-
CESC	cis	rs950880	0.71	rs17027060	MIMAT0019927	hsa-miR-4772-3p	5.07	8.43e-07	0.33	0.32	Serum protein levels (sST2);	chr2:102391107	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs66919607	MIMAT0019927	hsa-miR-4772-3p	5.07	8.43e-07	0.33	0.32	Serum protein levels (sST2);	chr2:102392509	chr2:102432336~102432357:+
CESC	cis	rs6841433	1	rs35217170	MIMAT0003242	hsa-miR-577	5.07	8.52e-07	0.5	0.32	Hemoglobin concentration;	chr4:114672701	chr4:114656774~114656794:+
CESC	cis	rs1712517	0.873	rs7916056	MIMAT0005951	hsa-miR-1307-3p	5.06	8.71e-07	0.25	0.32	Migraine;	chr10:103238157	chr10:103394301~103394322:-
CESC	cis	rs950880	0.71	rs55742125	MIMAT0019927	hsa-miR-4772-3p	5.06	8.83e-07	0.33	0.32	Serum protein levels (sST2);	chr2:102403322	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs55883125	MIMAT0019927	hsa-miR-4772-3p	5.06	8.83e-07	0.33	0.32	Serum protein levels (sST2);	chr2:102407871	chr2:102432336~102432357:+
CESC	cis	rs950880	0.645	rs4851006	MIMAT0019927	hsa-miR-4772-3p	5.06	8.83e-07	0.33	0.32	Serum protein levels (sST2);	chr2:102408278	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.572	rs17027173	MIMAT0019927	hsa-miR-4772-3p	-5.06	9e-07	-0.39	-0.32	Blood protein levels;	chr2:102440583	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs1135354	MIMAT0019927	hsa-miR-4772-3p	5.06	9.07e-07	0.33	0.32	Serum protein levels (sST2);	chr2:102397842	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs3732123	MIMAT0019927	hsa-miR-4772-3p	5.05	9.38e-07	0.33	0.32	Serum protein levels (sST2);	chr2:102401617	chr2:102432336~102432357:+
CESC	cis	rs950880	0.668	rs3732126	MIMAT0019927	hsa-miR-4772-3p	5.04	9.6e-07	0.33	0.32	Serum protein levels (sST2);	chr2:102397502	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs3732125	MIMAT0019927	hsa-miR-4772-3p	5.04	9.6e-07	0.33	0.32	Serum protein levels (sST2);	chr2:102397503	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs17027071	MIMAT0019927	hsa-miR-4772-3p	5.04	9.89e-07	0.33	0.32	Serum protein levels (sST2);	chr2:102396214	chr2:102432336~102432357:+
CESC	cis	rs1712517	0.566	rs1163073	MIMAT0005951	hsa-miR-1307-3p	5.04	9.93e-07	0.27	0.32	Migraine;	chr10:103263177	chr10:103394301~103394322:-
CESC	cis	rs75358501	0.636	rs10199766	MIMAT0014994	hsa-miR-3130-3p	5.03	1.03e-06	0.43	0.32	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783245~206783265:-
CESC	cis	rs75358501	0.636	rs10199766	MIMAT0014994_1	hsa-miR-3130-3p	5.03	1.03e-06	0.43	0.32	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783277~206783297:+
CESC	cis	rs75358501	0.636	rs13427002	MIMAT0014994	hsa-miR-3130-3p	5.03	1.03e-06	0.43	0.32	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783245~206783265:-
CESC	cis	rs75358501	0.636	rs13427002	MIMAT0014994_1	hsa-miR-3130-3p	5.03	1.03e-06	0.43	0.32	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783277~206783297:+
CESC	cis	rs6841433	1	rs10008981	MIMAT0003242	hsa-miR-577	5.01	1.1e-06	0.49	0.32	Hemoglobin concentration;	chr4:114650189	chr4:114656774~114656794:+
CESC	cis	rs6841433	1	rs35271056	MIMAT0003242	hsa-miR-577	5	1.15e-06	0.49	0.32	Hemoglobin concentration;	chr4:114642195	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.948	rs7671477	MIMAT0003242	hsa-miR-577	4.99	1.23e-06	0.49	0.32	Hemoglobin concentration;	chr4:114632518	chr4:114656774~114656794:+
CESC	cis	rs6841433	1	rs6533803	MIMAT0003242	hsa-miR-577	4.99	1.23e-06	0.49	0.32	Hemoglobin concentration;	chr4:114637085	chr4:114656774~114656794:+
CESC	cis	rs6841433	1	rs10049660	MIMAT0003242	hsa-miR-577	4.99	1.23e-06	0.49	0.32	Hemoglobin concentration;	chr4:114637758	chr4:114656774~114656794:+
CESC	cis	rs950880	0.71	rs3821204	MIMAT0019927	hsa-miR-4772-3p	4.98	1.31e-06	0.34	0.32	Serum protein levels (sST2);	chr2:102343821	chr2:102432336~102432357:+
CESC	cis	rs75358501	0.636	rs725980	MIMAT0014994	hsa-miR-3130-3p	4.96	1.4e-06	0.43	0.32	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783245~206783265:-
CESC	cis	rs75358501	0.636	rs725980	MIMAT0014994_1	hsa-miR-3130-3p	4.96	1.4e-06	0.43	0.32	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783277~206783297:+
CESC	cis	rs7072216	0.763	rs10883091	MIMAT0026738	hsa-miR-1287-3p	4.96	1.41e-06	0.29	0.32	Metabolite levels;	chr10:98407482	chr10:98395232~98395253:-
CESC	cis	rs1712517	0.566	rs7076274	MIMAT0005951	hsa-miR-1307-3p	-4.96	1.41e-06	-0.26	-0.32	Migraine;	chr10:103286250	chr10:103394301~103394322:-
CESC	cis	rs1712517	0.545	rs3740381	MIMAT0005951	hsa-miR-1307-3p	-4.96	1.41e-06	-0.26	-0.32	Migraine;	chr10:103286932	chr10:103394301~103394322:-
CESC	cis	rs1712517	0.525	rs7911488	MIMAT0005951	hsa-miR-1307-3p	-4.96	1.42e-06	-0.26	-0.32	Migraine;	chr10:103394332	chr10:103394301~103394322:-
CESC	cis	rs950880	0.677	rs17027087	MIMAT0019927	hsa-miR-4772-3p	4.95	1.45e-06	0.32	0.32	Serum protein levels (sST2);	chr2:102399458	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs12905	MIMAT0019927	hsa-miR-4772-3p	4.95	1.51e-06	0.34	0.32	Serum protein levels (sST2);	chr2:102343547	chr2:102432336~102432357:+
CESC	cis	rs6841433	1	rs34546485	MIMAT0003242	hsa-miR-577	4.94	1.52e-06	0.48	0.32	Hemoglobin concentration;	chr4:114693882	chr4:114656774~114656794:+
CESC	cis	rs7072216	0.763	rs6584202	MIMAT0026738	hsa-miR-1287-3p	4.94	1.58e-06	0.28	0.32	Metabolite levels;	chr10:98410626	chr10:98395232~98395253:-
CESC	cis	rs950880	0.71	rs2287034	MIMAT0019927	hsa-miR-4772-3p	-4.92	1.71e-06	-0.32	-0.32	Serum protein levels (sST2);	chr2:102394128	chr2:102432336~102432357:+
CESC	cis	rs7072216	0.763	rs10883092	MIMAT0026738	hsa-miR-1287-3p	4.89	1.96e-06	0.29	0.31	Metabolite levels;	chr10:98407519	chr10:98395232~98395253:-
CESC	cis	rs12712135	0.709	rs10201184	MIMAT0019927	hsa-miR-4772-3p	-4.89	2e-06	-0.29	-0.31	Blood protein levels;	chr2:102472618	chr2:102432336~102432357:+
CESC	cis	rs12712135	0.709	rs12463588	MIMAT0019927	hsa-miR-4772-3p	4.88	2.01e-06	0.29	0.31	Blood protein levels;	chr2:102468797	chr2:102432336~102432357:+
CESC	cis	rs12712135	0.709	rs2310302	MIMAT0019927	hsa-miR-4772-3p	4.88	2.01e-06	0.29	0.31	Blood protein levels;	chr2:102469589	chr2:102432336~102432357:+
CESC	cis	rs12712135	0.709	rs12469887	MIMAT0019927	hsa-miR-4772-3p	4.88	2.01e-06	0.29	0.31	Blood protein levels;	chr2:102470298	chr2:102432336~102432357:+
CESC	cis	rs12712135	0.709	rs4140786	MIMAT0019927	hsa-miR-4772-3p	4.88	2.01e-06	0.29	0.31	Blood protein levels;	chr2:102471716	chr2:102432336~102432357:+
CESC	cis	rs12712135	0.651	rs12712150	MIMAT0019927	hsa-miR-4772-3p	4.87	2.11e-06	0.29	0.31	Blood protein levels;	chr2:102458353	chr2:102432336~102432357:+
CESC	cis	rs7072216	0.763	rs7909822	MIMAT0026738	hsa-miR-1287-3p	4.87	2.12e-06	0.28	0.31	Metabolite levels;	chr10:98412278	chr10:98395232~98395253:-
CESC	cis	rs6841433	1	rs13133286	MIMAT0003242	hsa-miR-577	4.85	2.32e-06	0.47	0.31	Hemoglobin concentration;	chr4:114701654	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.948	rs34110012	MIMAT0003242	hsa-miR-577	4.85	2.32e-06	0.47	0.31	Hemoglobin concentration;	chr4:114710498	chr4:114656774~114656794:+
CESC	cis	rs75358501	0.636	rs7576591	MIMAT0014994	hsa-miR-3130-3p	4.85	2.39e-06	0.41	0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783245~206783265:-
CESC	cis	rs75358501	0.636	rs7576591	MIMAT0014994_1	hsa-miR-3130-3p	4.85	2.39e-06	0.41	0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783277~206783297:+
CESC	cis	rs1712517	0.566	rs7917388	MIMAT0005951	hsa-miR-1307-3p	-4.84	2.41e-06	-0.26	-0.31	Migraine;	chr10:103295206	chr10:103394301~103394322:-
CESC	cis	rs1712517	0.503	rs72846198	MIMAT0005951	hsa-miR-1307-3p	-4.84	2.48e-06	-0.26	-0.31	Migraine;	chr10:103338267	chr10:103394301~103394322:-
CESC	cis	rs950880	0.71	rs55927292	MIMAT0019927	hsa-miR-4772-3p	4.83	2.61e-06	0.32	0.31	Serum protein levels (sST2);	chr2:102348401	chr2:102432336~102432357:+
CESC	cis	rs1712517	0.526	rs113528138	MIMAT0005951	hsa-miR-1307-3p	-4.82	2.72e-06	-0.25	-0.31	Migraine;	chr10:103365694	chr10:103394301~103394322:-
CESC	cis	rs75358501	0.636	rs2287628	MIMAT0014994	hsa-miR-3130-3p	4.82	2.72e-06	0.41	0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783245~206783265:-
CESC	cis	rs75358501	0.636	rs2287628	MIMAT0014994_1	hsa-miR-3130-3p	4.82	2.72e-06	0.41	0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783277~206783297:+
CESC	cis	rs12712135	0.709	rs11465730	MIMAT0019927	hsa-miR-4772-3p	4.81	2.78e-06	0.28	0.31	Blood protein levels;	chr2:102450398	chr2:102432336~102432357:+
CESC	cis	rs12712135	0.677	rs11678721	MIMAT0019927	hsa-miR-4772-3p	4.81	2.8e-06	0.28	0.31	Blood protein levels;	chr2:102456778	chr2:102432336~102432357:+
CESC	cis	rs12712135	0.709	rs11677555	MIMAT0019927	hsa-miR-4772-3p	4.81	2.8e-06	0.28	0.31	Blood protein levels;	chr2:102456833	chr2:102432336~102432357:+
CESC	cis	rs12712135	0.677	rs6705385	MIMAT0019927	hsa-miR-4772-3p	4.81	2.8e-06	0.28	0.31	Blood protein levels;	chr2:102460109	chr2:102432336~102432357:+
CESC	cis	rs12712135	0.709	rs6705498	MIMAT0019927	hsa-miR-4772-3p	4.81	2.8e-06	0.28	0.31	Blood protein levels;	chr2:102460210	chr2:102432336~102432357:+
CESC	cis	rs12712135	0.709	rs6719196	MIMAT0019927	hsa-miR-4772-3p	4.81	2.8e-06	0.28	0.31	Blood protein levels;	chr2:102460428	chr2:102432336~102432357:+
CESC	cis	rs12712135	0.709	rs11676236	MIMAT0019927	hsa-miR-4772-3p	4.81	2.8e-06	0.28	0.31	Blood protein levels;	chr2:102465235	chr2:102432336~102432357:+
CESC	cis	rs12712135	0.677	rs11687013	MIMAT0019927	hsa-miR-4772-3p	4.81	2.8e-06	0.28	0.31	Blood protein levels;	chr2:102465261	chr2:102432336~102432357:+
CESC	cis	rs1712517	0.873	rs7903004	MIMAT0005951	hsa-miR-1307-3p	4.8	2.97e-06	0.23	0.31	Migraine;	chr10:103244344	chr10:103394301~103394322:-
CESC	cis	rs950880	0.71	rs56331791	MIMAT0019927	hsa-miR-4772-3p	4.79	3.08e-06	0.32	0.31	Serum protein levels (sST2);	chr2:102431697	chr2:102432336~102432357:+
CESC	cis	rs4921799	0.618	rs35985354	MIMAT0015020	hsa-miR-548v	-4.79	3.12e-06	-0.36	-0.31	Lung cancer;Adenocarcinoma;	chr8:17680894	chr8:17681588~17681609:-
CESC	cis	rs4921799	0.662	rs57661227	MIMAT0015020	hsa-miR-548v	-4.79	3.12e-06	-0.36	-0.31	Lung cancer;Adenocarcinoma;	chr8:17680912	chr8:17681588~17681609:-
CESC	cis	rs6841433	1	rs55875005	MIMAT0003242	hsa-miR-577	4.78	3.15e-06	0.46	0.31	Hemoglobin concentration;	chr4:114691920	chr4:114656774~114656794:+
CESC	cis	rs453301	0.686	rs6601280	MIMAT0019728	hsa-miR-4660	4.77	3.32e-06	0.4	0.31	Joint mobility (Beighton score);	chr8:9051726	chr8:9048453~9048475:+
CESC	cis	rs12712135	0.652	rs11465727	MIMAT0019927	hsa-miR-4772-3p	4.77	3.32e-06	0.28	0.31	Blood protein levels;	chr2:102448043	chr2:102432336~102432357:+
CESC	cis	rs12712135	0.709	rs11465729	MIMAT0019927	hsa-miR-4772-3p	4.77	3.32e-06	0.28	0.31	Blood protein levels;	chr2:102448052	chr2:102432336~102432357:+
CESC	cis	rs1712517	0.525	rs11191642	MIMAT0005951	hsa-miR-1307-3p	-4.77	3.34e-06	-0.26	-0.31	Migraine;	chr10:103296155	chr10:103394301~103394322:-
CESC	cis	rs1712517	0.844	rs1163075	MIMAT0005951	hsa-miR-1307-3p	4.77	3.38e-06	0.23	0.31	Migraine;	chr10:103261506	chr10:103394301~103394322:-
CESC	cis	rs75358501	0.636	rs16838834	MIMAT0014994	hsa-miR-3130-3p	4.77	3.43e-06	0.42	0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783245~206783265:-
CESC	cis	rs75358501	0.636	rs16838834	MIMAT0014994_1	hsa-miR-3130-3p	4.77	3.43e-06	0.42	0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783277~206783297:+
CESC	cis	rs453301	0.658	rs6983877	MIMAT0019728	hsa-miR-4660	-4.76	3.54e-06	-0.38	-0.31	Joint mobility (Beighton score);	chr8:9047129	chr8:9048453~9048475:+
CESC	cis	rs950880	0.71	rs17027258	MIMAT0019927	hsa-miR-4772-3p	4.75	3.63e-06	0.31	0.31	Serum protein levels (sST2);	chr2:102475081	chr2:102432336~102432357:+
CESC	cis	rs6799788	0.54	rs17826053	MIMAT0000417	hsa-miR-15b-5p	-4.74	3.93e-06	-0.39	-0.31	Major depressive disorder;	chr3:159999842	chr3:160404607~160404628:+
CESC	cis	rs950880	0.593	rs887971	MIMAT0019927	hsa-miR-4772-3p	4.73	3.96e-06	0.3	0.31	Serum protein levels (sST2);	chr2:102424707	chr2:102432336~102432357:+
CESC	cis	rs1712517	0.873	rs7894240	MIMAT0005951	hsa-miR-1307-3p	4.73	4.09e-06	0.23	0.3	Migraine;	chr10:103240612	chr10:103394301~103394322:-
CESC	cis	rs950880	0.767	rs6710885	MIMAT0019927	hsa-miR-4772-3p	-4.72	4.17e-06	-0.31	-0.3	Serum protein levels (sST2);	chr2:102361077	chr2:102432336~102432357:+
CESC	cis	rs950880	0.767	rs2287037	MIMAT0019927	hsa-miR-4772-3p	4.72	4.2e-06	0.31	0.3	Serum protein levels (sST2);	chr2:102362568	chr2:102432336~102432357:+
CESC	cis	rs950880	0.767	rs11123923	MIMAT0019927	hsa-miR-4772-3p	4.72	4.21e-06	0.31	0.3	Serum protein levels (sST2);	chr2:102351384	chr2:102432336~102432357:+
CESC	cis	rs9814567	1	rs4535272	MIMAT0019958	hsa-miR-4788	-4.72	4.27e-06	-0.38	-0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134581074	chr3:134437836~134437857:+
CESC	cis	rs1712517	0.588	rs12220267	MIMAT0005951	hsa-miR-1307-3p	-4.72	4.3e-06	-0.25	-0.3	Migraine;	chr10:103315955	chr10:103394301~103394322:-
CESC	cis	rs4921799	0.64	rs11203895	MIMAT0015020	hsa-miR-548v	-4.72	4.3e-06	-0.34	-0.3	Lung cancer;Adenocarcinoma;	chr8:17678085	chr8:17681588~17681609:-
CESC	cis	rs17027258	0.697	rs1468789	MIMAT0019927	hsa-miR-4772-3p	4.72	4.3e-06	0.34	0.3	White blood cell types;	chr2:102476044	chr2:102432336~102432357:+
CESC	cis	rs1163656	0.605	rs7487519	MIMAT0003287	hsa-miR-618	-4.71	4.32e-06	-0.39	-0.3	Dental caries;	chr12:80921469	chr12:80935796~80935818:-
CESC	cis	rs6841433	1	rs6841433	MIMAT0003242	hsa-miR-577	4.71	4.35e-06	0.46	0.3	Hemoglobin concentration;	chr4:114647874	chr4:114656774~114656794:+
CESC	cis	rs950880	0.593	rs887972	MIMAT0019927	hsa-miR-4772-3p	4.71	4.41e-06	0.3	0.3	Serum protein levels (sST2);	chr2:102424485	chr2:102432336~102432357:+
CESC	cis	rs950880	0.796	rs12987977	MIMAT0019927	hsa-miR-4772-3p	4.71	4.43e-06	0.31	0.3	Serum protein levels (sST2);	chr2:102358876	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs4851011	MIMAT0019927	hsa-miR-4772-3p	-4.71	4.5e-06	-0.32	-0.3	Serum protein levels (sST2);	chr2:102473219	chr2:102432336~102432357:+
CESC	cis	rs12712135	0.709	rs11465728	MIMAT0019927	hsa-miR-4772-3p	4.7	4.51e-06	0.28	0.3	Blood protein levels;	chr2:102448051	chr2:102432336~102432357:+
CESC	cis	rs12712135	0.709	rs10195075	MIMAT0019927	hsa-miR-4772-3p	4.7	4.52e-06	0.28	0.3	Blood protein levels;	chr2:102471192	chr2:102432336~102432357:+
CESC	cis	rs12712135	0.709	rs1403553	MIMAT0019927	hsa-miR-4772-3p	4.7	4.52e-06	0.28	0.3	Blood protein levels;	chr2:102471202	chr2:102432336~102432357:+
CESC	cis	rs453301	0.658	rs12114954	MIMAT0019728	hsa-miR-4660	-4.7	4.56e-06	-0.38	-0.3	Joint mobility (Beighton score);	chr8:9047352	chr8:9048453~9048475:+
CESC	cis	rs950880	0.71	rs66566526	MIMAT0019927	hsa-miR-4772-3p	4.7	4.64e-06	0.31	0.3	Serum protein levels (sST2);	chr2:102431342	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs4851582	MIMAT0019927	hsa-miR-4772-3p	4.7	4.64e-06	0.31	0.3	Serum protein levels (sST2);	chr2:102435098	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.693	rs7579737	MIMAT0019927	hsa-miR-4772-3p	-4.7	4.71e-06	-0.34	-0.3	Blood protein levels;	chr2:102370901	chr2:102432336~102432357:+
CESC	cis	rs950880	0.56	rs1362349	MIMAT0019927	hsa-miR-4772-3p	4.69	4.82e-06	0.28	0.3	Serum protein levels (sST2);	chr2:102335512	chr2:102432336~102432357:+
CESC	cis	rs950880	0.767	rs4851569	MIMAT0019927	hsa-miR-4772-3p	4.69	4.82e-06	0.31	0.3	Serum protein levels (sST2);	chr2:102366787	chr2:102432336~102432357:+
CESC	cis	rs7072216	0.763	rs8181292	MIMAT0026738	hsa-miR-1287-3p	4.68	4.97e-06	0.27	0.3	Metabolite levels;	chr10:98415720	chr10:98395232~98395253:-
CESC	cis	rs950880	0.71	rs11681718	MIMAT0019927	hsa-miR-4772-3p	4.68	5.03e-06	0.32	0.3	Serum protein levels (sST2);	chr2:102434684	chr2:102432336~102432357:+
CESC	cis	rs6841433	0.948	rs9884805	MIMAT0003242	hsa-miR-577	4.68	5.1e-06	0.46	0.3	Hemoglobin concentration;	chr4:114697040	chr4:114656774~114656794:+
CESC	cis	rs950880	0.767	rs1420098	MIMAT0019927	hsa-miR-4772-3p	4.68	5.14e-06	0.31	0.3	Serum protein levels (sST2);	chr2:102367819	chr2:102432336~102432357:+
CESC	cis	rs950880	0.699	rs1882348	MIMAT0019927	hsa-miR-4772-3p	4.68	5.14e-06	0.31	0.3	Serum protein levels (sST2);	chr2:102368211	chr2:102432336~102432357:+
CESC	cis	rs7072216	0.763	rs2147900	MIMAT0026738	hsa-miR-1287-3p	4.67	5.16e-06	0.27	0.3	Metabolite levels;	chr10:98414964	chr10:98395232~98395253:-
CESC	cis	rs950880	0.71	rs17027255	MIMAT0019927	hsa-miR-4772-3p	4.67	5.17e-06	0.31	0.3	Serum protein levels (sST2);	chr2:102473668	chr2:102432336~102432357:+
CESC	cis	rs6543140	0.964	rs4851589	MIMAT0019927	hsa-miR-4772-3p	-4.67	5.34e-06	-0.32	-0.3	Blood protein levels;	chr2:102460685	chr2:102432336~102432357:+
CESC	cis	rs4921799	0.662	rs17690083	MIMAT0015020	hsa-miR-548v	-4.66	5.39e-06	-0.35	-0.3	Lung cancer;Adenocarcinoma;	chr8:17680756	chr8:17681588~17681609:-
CESC	cis	rs75358501	0.688	rs28365797	MIMAT0014994	hsa-miR-3130-3p	4.66	5.44e-06	0.41	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783245~206783265:-
CESC	cis	rs75358501	0.688	rs28365797	MIMAT0014994_1	hsa-miR-3130-3p	4.66	5.44e-06	0.41	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783277~206783297:+
CESC	cis	rs7072216	0.763	rs10883090	MIMAT0026738	hsa-miR-1287-3p	4.66	5.49e-06	0.28	0.3	Metabolite levels;	chr10:98407479	chr10:98395232~98395253:-
CESC	cis	rs10021731	0.546	rs12503437	MIMAT0003242	hsa-miR-577	-4.66	5.51e-06	-0.31	-0.3	Optic disc area;	chr4:114534955	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.546	rs12503481	MIMAT0003242	hsa-miR-577	-4.66	5.51e-06	-0.31	-0.3	Optic disc area;	chr4:114535080	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.546	rs7668023	MIMAT0003242	hsa-miR-577	-4.66	5.51e-06	-0.31	-0.3	Optic disc area;	chr4:114535366	chr4:114656774~114656794:+
CESC	cis	rs950880	0.71	rs3771150	MIMAT0019927	hsa-miR-4772-3p	4.66	5.55e-06	0.32	0.3	Serum protein levels (sST2);	chr2:102444391	chr2:102432336~102432357:+
CESC	cis	rs9814567	1	rs10935120	MIMAT0019958	hsa-miR-4788	-4.65	5.64e-06	-0.38	-0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134514250	chr3:134437836~134437857:+
CESC	cis	rs7072216	0.763	rs10736129	MIMAT0026738	hsa-miR-1287-3p	-4.65	5.72e-06	-0.27	-0.3	Metabolite levels;	chr10:98411814	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs9787550	MIMAT0026738	hsa-miR-1287-3p	4.65	5.83e-06	0.27	0.3	Metabolite levels;	chr10:98409294	chr10:98395232~98395253:-
CESC	cis	rs950880	0.767	rs12999364	MIMAT0019927	hsa-miR-4772-3p	4.64	6.07e-06	0.3	0.3	Serum protein levels (sST2);	chr2:102357669	chr2:102432336~102432357:+
CESC	cis	rs950880	0.767	rs12998521	MIMAT0019927	hsa-miR-4772-3p	4.64	6.07e-06	0.3	0.3	Serum protein levels (sST2);	chr2:102357957	chr2:102432336~102432357:+
CESC	cis	rs9814567	0.929	rs9855013	MIMAT0019958	hsa-miR-4788	4.64	6.08e-06	0.37	0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134521572	chr3:134437836~134437857:+
CESC	cis	rs950880	0.71	rs56166614	MIMAT0019927	hsa-miR-4772-3p	4.64	6.09e-06	0.31	0.3	Serum protein levels (sST2);	chr2:102439636	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs11678975	MIMAT0019927	hsa-miR-4772-3p	4.64	6.11e-06	0.31	0.3	Serum protein levels (sST2);	chr2:102427279	chr2:102432336~102432357:+
CESC	cis	rs7072216	0.763	rs3750601	MIMAT0026738	hsa-miR-1287-3p	4.64	6.12e-06	0.27	0.3	Metabolite levels;	chr10:98414804	chr10:98395232~98395253:-
CESC	cis	rs9814567	0.964	rs6776203	MIMAT0019958	hsa-miR-4788	4.63	6.23e-06	0.37	0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134515503	chr3:134437836~134437857:+
CESC	cis	rs75358501	0.636	rs888621	MIMAT0014994	hsa-miR-3130-3p	-4.63	6.23e-06	-0.39	-0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783245~206783265:-
CESC	cis	rs75358501	0.636	rs888621	MIMAT0014994_1	hsa-miR-3130-3p	-4.63	6.23e-06	-0.39	-0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783277~206783297:+
CESC	cis	rs7072216	0.763	rs12259939	MIMAT0026738	hsa-miR-1287-3p	4.63	6.23e-06	0.27	0.3	Metabolite levels;	chr10:98409264	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs7923729	MIMAT0026738	hsa-miR-1287-3p	4.63	6.23e-06	0.27	0.3	Metabolite levels;	chr10:98409708	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.806	rs9804285	MIMAT0026738	hsa-miR-1287-3p	4.63	6.23e-06	0.27	0.3	Metabolite levels;	chr10:98409715	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs6584198	MIMAT0026738	hsa-miR-1287-3p	4.63	6.23e-06	0.27	0.3	Metabolite levels;	chr10:98410149	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.727	rs6584199	MIMAT0026738	hsa-miR-1287-3p	4.63	6.23e-06	0.27	0.3	Metabolite levels;	chr10:98410226	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs6584200	MIMAT0026738	hsa-miR-1287-3p	4.63	6.23e-06	0.27	0.3	Metabolite levels;	chr10:98410280	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs6584201	MIMAT0026738	hsa-miR-1287-3p	4.63	6.23e-06	0.27	0.3	Metabolite levels;	chr10:98410452	chr10:98395232~98395253:-
CESC	cis	rs4921799	0.64	rs28716839	MIMAT0015020	hsa-miR-548v	-4.62	6.54e-06	-0.35	-0.3	Lung cancer;Adenocarcinoma;	chr8:17680463	chr8:17681588~17681609:-
CESC	cis	rs6681460	0.565	rs1536112	MIMAT0014979	hsa-miR-3117-3p	4.62	6.61e-06	0.36	0.3	Presence of antiphospholipid antibodies;	chr1:66641542	chr1:66628485~66628505:+
CESC	cis	rs7072216	0.763	rs942804	MIMAT0026738	hsa-miR-1287-3p	4.62	6.67e-06	0.28	0.3	Metabolite levels;	chr10:98408742	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs942805	MIMAT0026738	hsa-miR-1287-3p	4.62	6.69e-06	0.28	0.3	Metabolite levels;	chr10:98408615	chr10:98395232~98395253:-
CESC	cis	rs75358501	0.636	rs2241347	MIMAT0014994	hsa-miR-3130-3p	4.61	6.76e-06	0.39	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783245~206783265:-
CESC	cis	rs75358501	0.636	rs2241347	MIMAT0014994_1	hsa-miR-3130-3p	4.61	6.76e-06	0.39	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783277~206783297:+
CESC	cis	rs1712517	0.844	rs1163074	MIMAT0005951	hsa-miR-1307-3p	-4.61	6.89e-06	-0.23	-0.3	Migraine;	chr10:103262005	chr10:103394301~103394322:-
CESC	cis	rs950880	0.71	rs4140785	MIMAT0019927	hsa-miR-4772-3p	4.6	7.09e-06	0.31	0.3	Serum protein levels (sST2);	chr2:102472057	chr2:102432336~102432357:+
CESC	cis	rs9814567	1	rs7648990	MIMAT0019958	hsa-miR-4788	4.6	7.11e-06	0.37	0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134525548	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.896	rs2177602	MIMAT0019958	hsa-miR-4788	4.6	7.11e-06	0.37	0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134527024	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs9863786	MIMAT0019958	hsa-miR-4788	4.6	7.11e-06	0.37	0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134528361	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs7611828	MIMAT0019958	hsa-miR-4788	4.6	7.11e-06	0.37	0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134531483	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs7428326	MIMAT0019958	hsa-miR-4788	4.6	7.11e-06	0.37	0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134532342	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs9884031	MIMAT0019958	hsa-miR-4788	4.6	7.11e-06	0.37	0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134537658	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs6439487	MIMAT0019958	hsa-miR-4788	4.6	7.11e-06	0.37	0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134542018	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs9835204	MIMAT0019958	hsa-miR-4788	4.6	7.11e-06	0.37	0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134542500	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs9828815	MIMAT0019958	hsa-miR-4788	4.6	7.11e-06	0.37	0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134546907	chr3:134437836~134437857:+
CESC	cis	rs1163656	0.572	rs7303026	MIMAT0003287	hsa-miR-618	-4.6	7.28e-06	-0.38	-0.3	Dental caries;	chr12:80921967	chr12:80935796~80935818:-
CESC	cis	rs1163656	0.572	rs7134652	MIMAT0003287	hsa-miR-618	-4.6	7.28e-06	-0.38	-0.3	Dental caries;	chr12:80922054	chr12:80935796~80935818:-
CESC	cis	rs1163656	0.572	rs7134827	MIMAT0003287	hsa-miR-618	-4.6	7.28e-06	-0.38	-0.3	Dental caries;	chr12:80922229	chr12:80935796~80935818:-
CESC	cis	rs9814567	1	rs13081177	MIMAT0019958	hsa-miR-4788	-4.59	7.35e-06	-0.37	-0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134571018	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs4572812	MIMAT0019958	hsa-miR-4788	-4.59	7.35e-06	-0.37	-0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134572335	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs2373865	MIMAT0019958	hsa-miR-4788	-4.59	7.35e-06	-0.37	-0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134572714	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.963	rs36006513	MIMAT0019958	hsa-miR-4788	-4.59	7.35e-06	-0.37	-0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134573071	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs7630874	MIMAT0019958	hsa-miR-4788	-4.59	7.35e-06	-0.37	-0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134574449	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs4368544	MIMAT0019958	hsa-miR-4788	-4.59	7.35e-06	-0.37	-0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134581172	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs13090969	MIMAT0019958	hsa-miR-4788	-4.59	7.35e-06	-0.37	-0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134588415	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs13071551	MIMAT0019958	hsa-miR-4788	-4.59	7.35e-06	-0.37	-0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134592025	chr3:134437836~134437857:+
CESC	cis	rs75358501	0.636	rs11895370	MIMAT0014994	hsa-miR-3130-3p	4.59	7.48e-06	0.4	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783245~206783265:-
CESC	cis	rs75358501	0.636	rs11895370	MIMAT0014994_1	hsa-miR-3130-3p	4.59	7.48e-06	0.4	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783277~206783297:+
CESC	cis	rs7072216	0.763	rs10732782	MIMAT0026738	hsa-miR-1287-3p	4.59	7.64e-06	0.27	0.3	Metabolite levels;	chr10:98406749	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs7911036	MIMAT0026738	hsa-miR-1287-3p	4.59	7.64e-06	0.27	0.3	Metabolite levels;	chr10:98407258	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs45523432	MIMAT0026738	hsa-miR-1287-3p	4.59	7.64e-06	0.27	0.3	Metabolite levels;	chr10:98407679	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs12763044	MIMAT0026738	hsa-miR-1287-3p	4.59	7.64e-06	0.27	0.3	Metabolite levels;	chr10:98407694	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.727	rs942808	MIMAT0026738	hsa-miR-1287-3p	4.59	7.64e-06	0.27	0.3	Metabolite levels;	chr10:98408345	chr10:98395232~98395253:-
CESC	cis	rs950880	0.71	rs56117144	MIMAT0019927	hsa-miR-4772-3p	4.58	7.8e-06	0.31	0.3	Serum protein levels (sST2);	chr2:102458191	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs57081652	MIMAT0019927	hsa-miR-4772-3p	4.58	7.8e-06	0.31	0.3	Serum protein levels (sST2);	chr2:102458921	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs10490204	MIMAT0019927	hsa-miR-4772-3p	4.58	7.88e-06	0.31	0.3	Serum protein levels (sST2);	chr2:102440074	chr2:102432336~102432357:+
CESC	cis	rs7072216	0.763	rs942803	MIMAT0026738	hsa-miR-1287-3p	4.57	8.1e-06	0.27	0.3	Metabolite levels;	chr10:98408874	chr10:98395232~98395253:-
CESC	cis	rs950880	0.71	rs55645612	MIMAT0019927	hsa-miR-4772-3p	4.57	8.31e-06	0.3	0.3	Serum protein levels (sST2);	chr2:102439201	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs17027179	MIMAT0019927	hsa-miR-4772-3p	4.57	8.31e-06	0.3	0.3	Serum protein levels (sST2);	chr2:102440699	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs11123927	MIMAT0019927	hsa-miR-4772-3p	4.57	8.31e-06	0.3	0.3	Serum protein levels (sST2);	chr2:102442343	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs10490203	MIMAT0019927	hsa-miR-4772-3p	4.57	8.31e-06	0.3	0.3	Serum protein levels (sST2);	chr2:102442777	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs4851583	MIMAT0019927	hsa-miR-4772-3p	4.57	8.31e-06	0.3	0.3	Serum protein levels (sST2);	chr2:102443840	chr2:102432336~102432357:+
CESC	cis	rs8026198	0.568	rs56670003	MIMAT0026623	hsa-miR-627-3p	4.57	8.32e-06	0.57	0.3	Fibrinogen levels;	chr15:42256236	chr15:42199593~42199612:-
CESC	cis	rs7072216	0.763	rs733345	MIMAT0026738	hsa-miR-1287-3p	4.57	8.33e-06	0.27	0.3	Metabolite levels;	chr10:98404458	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs733346	MIMAT0026738	hsa-miR-1287-3p	4.57	8.33e-06	0.27	0.3	Metabolite levels;	chr10:98404568	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.726	rs4474372	MIMAT0026738	hsa-miR-1287-3p	4.57	8.33e-06	0.27	0.3	Metabolite levels;	chr10:98404814	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs3814140	MIMAT0026738	hsa-miR-1287-3p	4.57	8.34e-06	0.27	0.3	Metabolite levels;	chr10:98411005	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs3814142	MIMAT0026738	hsa-miR-1287-3p	4.57	8.34e-06	0.27	0.3	Metabolite levels;	chr10:98411347	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.691	rs3829853	MIMAT0026738	hsa-miR-1287-3p	4.57	8.34e-06	0.27	0.3	Metabolite levels;	chr10:98411417	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.727	rs10748728	MIMAT0026738	hsa-miR-1287-3p	4.57	8.34e-06	0.27	0.3	Metabolite levels;	chr10:98411441	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs10748729	MIMAT0026738	hsa-miR-1287-3p	4.57	8.34e-06	0.27	0.3	Metabolite levels;	chr10:98411614	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs10748730	MIMAT0026738	hsa-miR-1287-3p	4.57	8.34e-06	0.27	0.3	Metabolite levels;	chr10:98411683	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs7910014	MIMAT0026738	hsa-miR-1287-3p	4.57	8.34e-06	0.27	0.3	Metabolite levels;	chr10:98412353	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs7910247	MIMAT0026738	hsa-miR-1287-3p	4.57	8.34e-06	0.27	0.3	Metabolite levels;	chr10:98412495	chr10:98395232~98395253:-
CESC	cis	rs9814567	0.929	rs1534027	MIMAT0019958	hsa-miR-4788	4.56	8.37e-06	0.37	0.3	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134565820	chr3:134437836~134437857:+
CESC	cis	rs453301	0.686	rs11787026	MIMAT0019728	hsa-miR-4660	4.56	8.46e-06	0.36	0.3	Joint mobility (Beighton score);	chr8:9044861	chr8:9048453~9048475:+
CESC	cis	rs950880	0.71	rs56043441	MIMAT0019927	hsa-miR-4772-3p	4.56	8.49e-06	0.3	0.3	Serum protein levels (sST2);	chr2:102470923	chr2:102432336~102432357:+
CESC	cis	rs6681460	0.565	rs6689755	MIMAT0014979	hsa-miR-3117-3p	-4.55	8.72e-06	-0.36	-0.29	Presence of antiphospholipid antibodies;	chr1:66647367	chr1:66628485~66628505:+
CESC	cis	rs7072216	0.763	rs2274245	MIMAT0026738	hsa-miR-1287-3p	4.55	8.93e-06	0.27	0.29	Metabolite levels;	chr10:98415325	chr10:98395232~98395253:-
CESC	cis	rs9814567	1	rs9809619	MIMAT0019958	hsa-miR-4788	4.55	8.97e-06	0.37	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134562106	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs1534026	MIMAT0019958	hsa-miR-4788	4.55	8.97e-06	0.37	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134565925	chr3:134437836~134437857:+
CESC	cis	rs950880	0.71	rs873022	MIMAT0019927	hsa-miR-4772-3p	4.55	8.99e-06	0.31	0.29	Serum protein levels (sST2);	chr2:102339223	chr2:102432336~102432357:+
CESC	cis	rs7072216	0.763	rs4475861	MIMAT0026738	hsa-miR-1287-3p	4.55	9e-06	0.27	0.29	Metabolite levels;	chr10:98405232	chr10:98395232~98395253:-
CESC	cis	rs453301	0.606	rs7462373	MIMAT0019728	hsa-miR-4660	-4.54	9.29e-06	-0.37	-0.29	Joint mobility (Beighton score);	chr8:9041808	chr8:9048453~9048475:+
CESC	cis	rs4921799	0.662	rs10888142	MIMAT0015020	hsa-miR-548v	-4.54	9.3e-06	-0.34	-0.29	Lung cancer;Adenocarcinoma;	chr8:17679605	chr8:17681588~17681609:-
CESC	cis	rs7072216	0.727	rs942807	MIMAT0026738	hsa-miR-1287-3p	4.54	9.32e-06	0.27	0.29	Metabolite levels;	chr10:98408462	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.691	rs7910973	MIMAT0026738	hsa-miR-1287-3p	4.53	9.55e-06	0.27	0.29	Metabolite levels;	chr10:98406975	chr10:98395232~98395253:-
CESC	cis	rs950880	0.56	rs66780767	MIMAT0019927	hsa-miR-4772-3p	4.53	9.81e-06	0.27	0.29	Serum protein levels (sST2);	chr2:102323249	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs1474309	MIMAT0019927	hsa-miR-4772-3p	4.53	9.85e-06	0.3	0.29	Serum protein levels (sST2);	chr2:102474542	chr2:102432336~102432357:+
CESC	cis	rs7072216	0.727	rs7913541	MIMAT0026738	hsa-miR-1287-3p	4.53	9.87e-06	0.26	0.29	Metabolite levels;	chr10:98412722	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs6584204	MIMAT0026738	hsa-miR-1287-3p	4.53	9.87e-06	0.26	0.29	Metabolite levels;	chr10:98413823	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs6584205	MIMAT0026738	hsa-miR-1287-3p	4.53	9.87e-06	0.26	0.29	Metabolite levels;	chr10:98414049	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs2274246	MIMAT0026738	hsa-miR-1287-3p	4.53	9.87e-06	0.26	0.29	Metabolite levels;	chr10:98415303	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs2274244	MIMAT0026738	hsa-miR-1287-3p	4.53	9.87e-06	0.26	0.29	Metabolite levels;	chr10:98415461	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs2274243	MIMAT0026738	hsa-miR-1287-3p	4.53	9.87e-06	0.26	0.29	Metabolite levels;	chr10:98415510	chr10:98395232~98395253:-
CESC	cis	rs4921799	0.662	rs11203898	MIMAT0015020	hsa-miR-548v	-4.52	1e-05	-0.34	-0.29	Lung cancer;Adenocarcinoma;	chr8:17679823	chr8:17681588~17681609:-
CESC	cis	rs4921799	0.662	rs11987569	MIMAT0015020	hsa-miR-548v	-4.52	1e-05	-0.34	-0.29	Lung cancer;Adenocarcinoma;	chr8:17680140	chr8:17681588~17681609:-
CESC	cis	rs9814567	0.964	rs9815894	MIMAT0019958	hsa-miR-4788	4.52	1.01e-05	0.37	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134563954	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.964	rs1534028	MIMAT0019958	hsa-miR-4788	4.52	1.01e-05	0.37	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134565797	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs55913793	MIMAT0019958	hsa-miR-4788	4.52	1.01e-05	0.37	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134567126	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs4955555	MIMAT0019958	hsa-miR-4788	4.52	1.01e-05	0.37	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134567585	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs9819532	MIMAT0019958	hsa-miR-4788	4.52	1.01e-05	0.37	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134569802	chr3:134437836~134437857:+
CESC	cis	rs9899728	0.572	rs9915968	MIMAT0017994	hsa-miR-3615	4.51	1.05e-05	0.34	0.29	Alzheimer's disease or small vessel stroke;	chr17:75063521	chr17:74748663~74748683:+
CESC	cis	rs453301	0.606	rs6601279	MIMAT0019728	hsa-miR-4660	-4.51	1.05e-05	-0.37	-0.29	Joint mobility (Beighton score);	chr8:9050721	chr8:9048453~9048475:+
CESC	cis	rs453301	0.606	rs6981060	MIMAT0019728	hsa-miR-4660	-4.51	1.05e-05	-0.37	-0.29	Joint mobility (Beighton score);	chr8:9050725	chr8:9048453~9048475:+
CESC	cis	rs9814567	1	rs11928499	MIMAT0019958	hsa-miR-4788	-4.51	1.06e-05	-0.37	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134513508	chr3:134437836~134437857:+
CESC	cis	rs950880	0.71	rs11123929	MIMAT0019927	hsa-miR-4772-3p	4.51	1.07e-05	0.3	0.29	Serum protein levels (sST2);	chr2:102450683	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs11123928	MIMAT0019927	hsa-miR-4772-3p	4.5	1.11e-05	0.3	0.29	Serum protein levels (sST2);	chr2:102444826	chr2:102432336~102432357:+
CESC	cis	rs1472147	1	rs6970221	MIMAT0000259	hsa-miR-182-5p	4.5	1.12e-05	0.3	0.29	Calcium levels;	chr7:128870970	chr7:129770447~129770470:-
CESC	cis	rs453301	0.686	rs6601281	MIMAT0019728	hsa-miR-4660	-4.5	1.12e-05	-0.37	-0.29	Joint mobility (Beighton score);	chr8:9053494	chr8:9048453~9048475:+
CESC	cis	rs950880	0.71	rs17027230	MIMAT0019927	hsa-miR-4772-3p	4.49	1.14e-05	0.3	0.29	Serum protein levels (sST2);	chr2:102462870	chr2:102432336~102432357:+
CESC	cis	rs950880	0.56	rs1558622	MIMAT0019927	hsa-miR-4772-3p	4.49	1.16e-05	0.27	0.29	Serum protein levels (sST2);	chr2:102313687	chr2:102432336~102432357:+
CESC	cis	rs950880	0.56	rs10189202	MIMAT0019927	hsa-miR-4772-3p	4.49	1.16e-05	0.27	0.29	Serum protein levels (sST2);	chr2:102313920	chr2:102432336~102432357:+
CESC	cis	rs950880	0.56	rs10191914	MIMAT0019927	hsa-miR-4772-3p	4.49	1.16e-05	0.27	0.29	Serum protein levels (sST2);	chr2:102314197	chr2:102432336~102432357:+
CESC	cis	rs1712517	0.835	rs2506961	MIMAT0005951	hsa-miR-1307-3p	4.48	1.19e-05	0.22	0.29	Migraine;	chr10:103248169	chr10:103394301~103394322:-
CESC	cis	rs1712517	0.873	rs1712510	MIMAT0005951	hsa-miR-1307-3p	4.48	1.19e-05	0.22	0.29	Migraine;	chr10:103249329	chr10:103394301~103394322:-
CESC	cis	rs950880	0.71	rs3771177	MIMAT0019927	hsa-miR-4772-3p	4.48	1.19e-05	0.31	0.29	Serum protein levels (sST2);	chr2:102339400	chr2:102432336~102432357:+
CESC	cis	rs950880	0.71	rs3732129	MIMAT0019927	hsa-miR-4772-3p	4.48	1.19e-05	0.31	0.29	Serum protein levels (sST2);	chr2:102341072	chr2:102432336~102432357:+
CESC	cis	rs950880	0.56	rs12712141	MIMAT0019927	hsa-miR-4772-3p	4.48	1.2e-05	0.27	0.29	Serum protein levels (sST2);	chr2:102336607	chr2:102432336~102432357:+
CESC	cis	rs6841433	0.615	rs33914856	MIMAT0003242	hsa-miR-577	4.48	1.22e-05	0.38	0.29	Hemoglobin concentration;	chr4:114564668	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.848	rs13328022	MIMAT0003242	hsa-miR-577	4.48	1.22e-05	0.43	0.29	Hemoglobin concentration;	chr4:114700701	chr4:114656774~114656794:+
CESC	cis	rs6841433	1	rs34403669	MIMAT0003242	hsa-miR-577	4.48	1.22e-05	0.43	0.29	Hemoglobin concentration;	chr4:114703735	chr4:114656774~114656794:+
CESC	cis	rs950880	0.56	rs13020793	MIMAT0019927	hsa-miR-4772-3p	4.48	1.23e-05	0.27	0.29	Serum protein levels (sST2);	chr2:102315466	chr2:102432336~102432357:+
CESC	cis	rs6681460	0.565	rs2147776	MIMAT0014979	hsa-miR-3117-3p	-4.47	1.25e-05	-0.36	-0.29	Presence of antiphospholipid antibodies;	chr1:66641720	chr1:66628485~66628505:+
CESC	cis	rs950880	0.56	rs12466380	MIMAT0019927	hsa-miR-4772-3p	4.47	1.28e-05	0.27	0.29	Serum protein levels (sST2);	chr2:102332479	chr2:102432336~102432357:+
CESC	cis	rs950880	0.56	rs1558620	MIMAT0019927	hsa-miR-4772-3p	4.47	1.28e-05	0.27	0.29	Serum protein levels (sST2);	chr2:102314935	chr2:102432336~102432357:+
CESC	cis	rs9899728	0.572	rs4365317	MIMAT0017994	hsa-miR-3615	4.47	1.28e-05	0.34	0.29	Alzheimer's disease or small vessel stroke;	chr17:75063725	chr17:74748663~74748683:+
CESC	cis	rs75358501	0.901	rs16838691	MIMAT0014995	hsa-miR-3130-5p	-4.46	1.29e-05	-0.5	-0.29	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.901	rs16838691	MIMAT0014995_1	hsa-miR-3130-5p	-4.46	1.29e-05	-0.5	-0.29	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783246~206783266:+
CESC	cis	rs950880	0.56	rs12712140	MIMAT0019927	hsa-miR-4772-3p	4.46	1.31e-05	0.27	0.29	Serum protein levels (sST2);	chr2:102334602	chr2:102432336~102432357:+
CESC	cis	rs950880	0.58	rs1997467	MIMAT0019927	hsa-miR-4772-3p	4.46	1.31e-05	0.27	0.29	Serum protein levels (sST2);	chr2:102334613	chr2:102432336~102432357:+
CESC	cis	rs1712517	0.838	rs6584543	MIMAT0005951	hsa-miR-1307-3p	4.46	1.33e-05	0.21	0.29	Migraine;	chr10:103237257	chr10:103394301~103394322:-
CESC	cis	rs9814567	1	rs6787371	MIMAT0019958	hsa-miR-4788	4.46	1.34e-05	0.36	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134536149	chr3:134437836~134437857:+
CESC	cis	rs950880	0.56	rs59247511	MIMAT0019927	hsa-miR-4772-3p	4.46	1.34e-05	0.27	0.29	Serum protein levels (sST2);	chr2:102337730	chr2:102432336~102432357:+
CESC	cis	rs12712135	0.706	rs6543114	MIMAT0019927	hsa-miR-4772-3p	4.45	1.39e-05	0.31	0.29	Blood protein levels;	chr2:102309534	chr2:102432336~102432357:+
CESC	cis	rs440932	0.565	rs19334	MIMAT0019728	hsa-miR-4660	4.45	1.39e-05	0.35	0.29	High light scatter reticulocyte percentage of red cells;	chr8:9152396	chr8:9048453~9048475:+
CESC	cis	rs9814567	1	rs7356093	MIMAT0019958	hsa-miR-4788	4.44	1.41e-05	0.36	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134519911	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.752	rs7649910	MIMAT0019958	hsa-miR-4788	4.44	1.41e-05	0.36	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134522468	chr3:134437836~134437857:+
CESC	cis	rs4921799	0.662	rs17125108	MIMAT0015020	hsa-miR-548v	-4.44	1.42e-05	-0.34	-0.29	Lung cancer;Adenocarcinoma;	chr8:17680832	chr8:17681588~17681609:-
CESC	cis	rs9814567	1	rs62271513	MIMAT0019958	hsa-miR-4788	-4.44	1.43e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134579570	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs4417907	MIMAT0019958	hsa-miR-4788	4.44	1.43e-05	0.36	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134572521	chr3:134437836~134437857:+
CESC	cis	rs7072216	0.727	rs942809	MIMAT0026738	hsa-miR-1287-3p	4.43	1.46e-05	0.26	0.29	Metabolite levels;	chr10:98408244	chr10:98395232~98395253:-
CESC	cis	rs6841433	0.571	rs13129837	MIMAT0003242	hsa-miR-577	4.43	1.47e-05	0.38	0.29	Hemoglobin concentration;	chr4:114563925	chr4:114656774~114656794:+
CESC	cis	rs950880	0.614	rs60038017	MIMAT0019927	hsa-miR-4772-3p	4.43	1.49e-05	0.29	0.29	Serum protein levels (sST2);	chr2:102459541	chr2:102432336~102432357:+
CESC	cis	rs7072216	0.763	rs7091709	MIMAT0026738	hsa-miR-1287-3p	4.43	1.5e-05	0.26	0.29	Metabolite levels;	chr10:98407848	chr10:98395232~98395253:-
CESC	cis	rs950880	0.71	rs11694360	MIMAT0019927	hsa-miR-4772-3p	4.42	1.54e-05	0.29	0.29	Serum protein levels (sST2);	chr2:102444687	chr2:102432336~102432357:+
CESC	cis	rs950880	0.677	rs4851585	MIMAT0019927	hsa-miR-4772-3p	4.42	1.54e-05	0.29	0.29	Serum protein levels (sST2);	chr2:102446294	chr2:102432336~102432357:+
CESC	cis	rs9814567	1	rs11919350	MIMAT0019958	hsa-miR-4788	-4.42	1.54e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134517128	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs7429866	MIMAT0019958	hsa-miR-4788	-4.42	1.54e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134517464	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs7433663	MIMAT0019958	hsa-miR-4788	4.42	1.54e-05	0.36	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134516948	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs9289475	MIMAT0019958	hsa-miR-4788	4.42	1.54e-05	0.36	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134517617	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs9851441	MIMAT0019958	hsa-miR-4788	4.42	1.55e-05	0.36	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134596249	chr3:134437836~134437857:+
CESC	cis	rs6841433	0.511	rs36078253	MIMAT0003242	hsa-miR-577	4.42	1.59e-05	0.38	0.29	Hemoglobin concentration;	chr4:114538112	chr4:114656774~114656794:+
CESC	cis	rs453301	0.686	rs17702602	MIMAT0019728	hsa-miR-4660	-4.42	1.59e-05	-0.37	-0.29	Joint mobility (Beighton score);	chr8:9051086	chr8:9048453~9048475:+
CESC	cis	rs1867631	0.958	rs7536188	MIMAT0014979	hsa-miR-3117-3p	4.41	1.6e-05	0.36	0.29	Menopause (age at onset);	chr1:66622243	chr1:66628485~66628505:+
CESC	cis	rs9814567	1	rs1534025	MIMAT0019958	hsa-miR-4788	-4.41	1.6e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134594462	chr3:134437836~134437857:+
CESC	cis	rs950880	0.56	rs11685480	MIMAT0019927	hsa-miR-4772-3p	4.41	1.64e-05	0.27	0.29	Serum protein levels (sST2);	chr2:102310626	chr2:102432336~102432357:+
CESC	cis	rs6841433	0.699	rs12643031	MIMAT0003242	hsa-miR-577	4.41	1.65e-05	0.38	0.29	Hemoglobin concentration;	chr4:114541449	chr4:114656774~114656794:+
CESC	cis	rs453301	0.658	rs3855900	MIMAT0019728	hsa-miR-4660	-4.4	1.68e-05	-0.36	-0.29	Joint mobility (Beighton score);	chr8:9044411	chr8:9048453~9048475:+
CESC	cis	rs9814567	1	rs6769885	MIMAT0019958	hsa-miR-4788	4.4	1.68e-05	0.36	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134568071	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs4367113	MIMAT0019958	hsa-miR-4788	4.4	1.68e-05	0.36	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134569133	chr3:134437836~134437857:+
CESC	cis	rs950880	0.553	rs2293225	MIMAT0019927	hsa-miR-4772-3p	4.4	1.68e-05	0.32	0.29	Serum protein levels (sST2);	chr2:102419429	chr2:102432336~102432357:+
CESC	cis	rs10021731	0.691	rs7654273	MIMAT0003242	hsa-miR-577	-4.4	1.68e-05	-0.3	-0.29	Optic disc area;	chr4:114501231	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.725	rs6839138	MIMAT0003242	hsa-miR-577	-4.4	1.68e-05	-0.3	-0.29	Optic disc area;	chr4:114501793	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.628	rs6533791	MIMAT0003242	hsa-miR-577	-4.4	1.7e-05	-0.3	-0.29	Optic disc area;	chr4:114491869	chr4:114656774~114656794:+
CESC	cis	rs6841433	1	rs6828127	MIMAT0003242	hsa-miR-577	4.4	1.72e-05	0.42	0.29	Hemoglobin concentration;	chr4:114689927	chr4:114656774~114656794:+
CESC	cis	rs1163656	0.534	rs12311427	MIMAT0003287	hsa-miR-618	-4.39	1.73e-05	-0.37	-0.29	Dental caries;	chr12:80934053	chr12:80935796~80935818:-
CESC	cis	rs9814567	0.793	rs55940445	MIMAT0019958	hsa-miR-4788	-4.39	1.75e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134587222	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs7637227	MIMAT0019958	hsa-miR-4788	4.39	1.75e-05	0.35	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134525313	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs9869981	MIMAT0019958	hsa-miR-4788	4.39	1.75e-05	0.35	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134529959	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs6439484	MIMAT0019958	hsa-miR-4788	4.39	1.75e-05	0.35	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134531057	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs7374158	MIMAT0019958	hsa-miR-4788	4.39	1.75e-05	0.35	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134551314	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs4309773	MIMAT0019958	hsa-miR-4788	4.39	1.75e-05	0.35	0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134558459	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs13059720	MIMAT0019958	hsa-miR-4788	-4.39	1.76e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134523179	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs2177601	MIMAT0019958	hsa-miR-4788	-4.39	1.76e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134526592	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs13096604	MIMAT0019958	hsa-miR-4788	-4.39	1.76e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134531257	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs28409322	MIMAT0019958	hsa-miR-4788	-4.39	1.76e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134533543	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs6763088	MIMAT0019958	hsa-miR-4788	-4.39	1.76e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134536147	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs6763093	MIMAT0019958	hsa-miR-4788	-4.39	1.76e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134536153	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs13081688	MIMAT0019958	hsa-miR-4788	-4.39	1.76e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134541112	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs13087875	MIMAT0019958	hsa-miR-4788	-4.39	1.76e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134542281	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs12637751	MIMAT0019958	hsa-miR-4788	-4.39	1.76e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134547282	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs11927068	MIMAT0019958	hsa-miR-4788	-4.39	1.76e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134547479	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs7426847	MIMAT0019958	hsa-miR-4788	-4.39	1.76e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134548677	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.928	rs6768323	MIMAT0019958	hsa-miR-4788	-4.39	1.76e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134549895	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs1880376	MIMAT0019958	hsa-miR-4788	-4.39	1.76e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134551505	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs1880377	MIMAT0019958	hsa-miR-4788	-4.39	1.76e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134551626	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs35718987	MIMAT0019958	hsa-miR-4788	-4.39	1.76e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134553941	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs13089966	MIMAT0019958	hsa-miR-4788	-4.39	1.76e-05	-0.36	-0.29	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134560355	chr3:134437836~134437857:+
CESC	cis	rs950880	0.71	rs17026974	MIMAT0019927	hsa-miR-4772-3p	-4.39	1.76e-05	-0.3	-0.29	Serum protein levels (sST2);	chr2:102335900	chr2:102432336~102432357:+
CESC	cis	rs6841433	0.706	rs13134858	MIMAT0003242	hsa-miR-577	4.39	1.76e-05	0.47	0.29	Hemoglobin concentration;	chr4:114601150	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.706	rs35571359	MIMAT0003242	hsa-miR-577	4.39	1.76e-05	0.47	0.29	Hemoglobin concentration;	chr4:114606130	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.706	rs35759252	MIMAT0003242	hsa-miR-577	4.39	1.76e-05	0.47	0.29	Hemoglobin concentration;	chr4:114608520	chr4:114656774~114656794:+
CESC	cis	rs75358501	0.636	rs3815686	MIMAT0014994	hsa-miR-3130-3p	4.39	1.79e-05	0.4	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783245~206783265:-
CESC	cis	rs75358501	0.636	rs3815686	MIMAT0014994_1	hsa-miR-3130-3p	4.39	1.79e-05	0.4	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783277~206783297:+
CESC	cis	rs950880	0.517	rs1968170	MIMAT0019927	hsa-miR-4772-3p	4.38	1.81e-05	0.26	0.28	Serum protein levels (sST2);	chr2:102317342	chr2:102432336~102432357:+
CESC	cis	rs950880	0.56	rs11123918	MIMAT0019927	hsa-miR-4772-3p	4.38	1.81e-05	0.26	0.28	Serum protein levels (sST2);	chr2:102318777	chr2:102432336~102432357:+
CESC	cis	rs950880	0.56	rs10182639	MIMAT0019927	hsa-miR-4772-3p	4.38	1.81e-05	0.26	0.28	Serum protein levels (sST2);	chr2:102319345	chr2:102432336~102432357:+
CESC	cis	rs9814567	1	rs7371896	MIMAT0019958	hsa-miR-4788	4.38	1.82e-05	0.36	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134530927	chr3:134437836~134437857:+
CESC	cis	rs8026198	0.568	rs57933952	MIMAT0026623	hsa-miR-627-3p	4.38	1.82e-05	0.52	0.28	Fibrinogen levels;	chr15:42257715	chr15:42199593~42199612:-
CESC	cis	rs1163656	0.572	rs1402349	MIMAT0003287	hsa-miR-618	-4.38	1.83e-05	-0.37	-0.28	Dental caries;	chr12:80919985	chr12:80935796~80935818:-
CESC	cis	rs950880	0.677	rs56224165	MIMAT0019927	hsa-miR-4772-3p	4.38	1.84e-05	0.31	0.28	Serum protein levels (sST2);	chr2:102308763	chr2:102432336~102432357:+
CESC	cis	rs1045529	0.524	rs34251783	MIMAT0019728	hsa-miR-4660	-4.38	1.85e-05	-0.35	-0.28	Myopia (pathological);Myopia;	chr8:9033866	chr8:9048453~9048475:+
CESC	cis	rs453301	0.686	rs11785634	MIMAT0019728	hsa-miR-4660	-4.38	1.85e-05	-0.35	-0.28	Joint mobility (Beighton score);	chr8:9035087	chr8:9048453~9048475:+
CESC	cis	rs7649443	0.759	rs3903682	MIMAT0019973	hsa-miR-4797-3p	-4.38	1.85e-05	-0.32	-0.28	Nonsyndromic cleft lip with cleft palate;	chr3:197280675	chr3:197293888~197293908:-
CESC	cis	rs7072216	0.763	rs12763326	MIMAT0026738	hsa-miR-1287-3p	-4.38	1.85e-05	-0.26	-0.28	Metabolite levels;	chr10:98407639	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.763	rs8181292	MIMAT0005878	hsa-miR-1287-5p	4.38	1.86e-05	0.27	0.28	Metabolite levels;	chr10:98415720	chr10:98395271~98395292:-
CESC	cis	rs950880	0.542	rs12996505	MIMAT0019927	hsa-miR-4772-3p	4.38	1.86e-05	0.26	0.28	Serum protein levels (sST2);	chr2:102315342	chr2:102432336~102432357:+
CESC	cis	rs453301	0.522	rs1964356	MIMAT0019728	hsa-miR-4660	4.38	1.87e-05	0.32	0.28	Joint mobility (Beighton score);	chr8:8995760	chr8:9048453~9048475:+
CESC	cis	rs950880	0.56	rs1997466	MIMAT0019927	hsa-miR-4772-3p	4.38	1.87e-05	0.26	0.28	Serum protein levels (sST2);	chr2:102335007	chr2:102432336~102432357:+
CESC	cis	rs10021731	0.725	rs6839694	MIMAT0003242	hsa-miR-577	-4.38	1.88e-05	-0.3	-0.28	Optic disc area;	chr4:114502041	chr4:114656774~114656794:+
CESC	cis	rs9814567	0.929	rs13088413	MIMAT0019958	hsa-miR-4788	-4.37	1.88e-05	-0.36	-0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134591135	chr3:134437836~134437857:+
CESC	cis	rs453301	0.719	rs34004903	MIMAT0019728	hsa-miR-4660	-4.37	1.89e-05	-0.35	-0.28	Joint mobility (Beighton score);	chr8:9035094	chr8:9048453~9048475:+
CESC	cis	rs453301	0.686	rs10217044	MIMAT0019728	hsa-miR-4660	-4.37	1.89e-05	-0.35	-0.28	Joint mobility (Beighton score);	chr8:9037242	chr8:9048453~9048475:+
CESC	cis	rs8026198	0.568	rs16972887	MIMAT0026623	hsa-miR-627-3p	4.37	1.89e-05	0.54	0.28	Fibrinogen levels;	chr15:42230360	chr15:42199593~42199612:-
CESC	cis	rs10021731	0.691	rs2126027	MIMAT0003242	hsa-miR-577	-4.37	1.89e-05	-0.3	-0.28	Optic disc area;	chr4:114533510	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.725	rs2126026	MIMAT0003242	hsa-miR-577	-4.37	1.89e-05	-0.3	-0.28	Optic disc area;	chr4:114533531	chr4:114656774~114656794:+
CESC	cis	rs950880	0.56	rs1362350	MIMAT0019927	hsa-miR-4772-3p	4.37	1.9e-05	0.26	0.28	Serum protein levels (sST2);	chr2:102335338	chr2:102432336~102432357:+
CESC	cis	rs1472147	1	rs6970221	MIMAT0000095	hsa-miR-96-5p	4.37	1.92e-05	0.29	0.28	Calcium levels;	chr7:128870970	chr7:129774739~129774761:-
CESC	cis	rs6841433	0.615	rs35789595	MIMAT0003242	hsa-miR-577	4.37	1.94e-05	0.38	0.28	Hemoglobin concentration;	chr4:114594055	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.571	rs35578985	MIMAT0003242	hsa-miR-577	4.37	1.94e-05	0.38	0.28	Hemoglobin concentration;	chr4:114594500	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs34001486	MIMAT0003242	hsa-miR-577	4.37	1.94e-05	0.38	0.28	Hemoglobin concentration;	chr4:114594792	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs13110751	MIMAT0003242	hsa-miR-577	4.36	1.98e-05	0.38	0.28	Hemoglobin concentration;	chr4:114563572	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs13105144	MIMAT0003242	hsa-miR-577	4.36	1.98e-05	0.38	0.28	Hemoglobin concentration;	chr4:114563873	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.691	rs10015704	MIMAT0003242	hsa-miR-577	-4.36	1.99e-05	-0.3	-0.28	Optic disc area;	chr4:114507972	chr4:114656774~114656794:+
CESC	cis	rs1472147	1	rs6970221	MIMAT0000261	hsa-miR-183-5p	4.36	2.01e-05	0.27	0.28	Calcium levels;	chr7:128870970	chr7:129774967~129774988:-
CESC	cis	rs1472147	1	rs13225751	MIMAT0000259	hsa-miR-182-5p	4.35	2.06e-05	0.3	0.28	Calcium levels;	chr7:128864475	chr7:129770447~129770470:-
CESC	cis	rs1472147	1	rs13226115	MIMAT0000259	hsa-miR-182-5p	4.35	2.06e-05	0.3	0.28	Calcium levels;	chr7:128864521	chr7:129770447~129770470:-
CESC	cis	rs10021731	0.725	rs36096691	MIMAT0003242	hsa-miR-577	4.35	2.09e-05	0.3	0.28	Optic disc area;	chr4:114509770	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.725	rs66806558	MIMAT0003242	hsa-miR-577	4.35	2.09e-05	0.3	0.28	Optic disc area;	chr4:114515499	chr4:114656774~114656794:+
CESC	cis	rs950880	0.71	rs7597017	MIMAT0019927	hsa-miR-4772-3p	4.35	2.13e-05	0.28	0.28	Serum protein levels (sST2);	chr2:102445656	chr2:102432336~102432357:+
CESC	cis	rs453301	0.686	rs1045527	MIMAT0019728	hsa-miR-4660	-4.34	2.14e-05	-0.35	-0.28	Joint mobility (Beighton score);	chr8:9032531	chr8:9048453~9048475:+
CESC	cis	rs7072216	0.763	rs6584202	MIMAT0005878	hsa-miR-1287-5p	4.34	2.15e-05	0.27	0.28	Metabolite levels;	chr10:98410626	chr10:98395271~98395292:-
CESC	cis	rs6841433	0.511	rs34534063	MIMAT0003242	hsa-miR-577	4.34	2.16e-05	0.38	0.28	Hemoglobin concentration;	chr4:114538077	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs7437576	MIMAT0003242	hsa-miR-577	4.34	2.16e-05	0.39	0.28	Hemoglobin concentration;	chr4:114595467	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.725	rs13103303	MIMAT0003242	hsa-miR-577	4.34	2.19e-05	0.3	0.28	Optic disc area;	chr4:114532477	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.725	rs7665770	MIMAT0003242	hsa-miR-577	-4.34	2.21e-05	-0.3	-0.28	Optic disc area;	chr4:114508383	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.725	rs11931563	MIMAT0003242	hsa-miR-577	4.33	2.26e-05	0.3	0.28	Optic disc area;	chr4:114496527	chr4:114656774~114656794:+
CESC	cis	rs453301	0.686	rs6987107	MIMAT0019728	hsa-miR-4660	-4.33	2.3e-05	-0.35	-0.28	Joint mobility (Beighton score);	chr8:9036071	chr8:9048453~9048475:+
CESC	cis	rs7072216	0.69	rs113195335	MIMAT0026738	hsa-miR-1287-3p	4.33	2.31e-05	0.25	0.28	Metabolite levels;	chr10:98415775	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.727	rs3750603	MIMAT0026738	hsa-miR-1287-3p	4.33	2.31e-05	0.25	0.28	Metabolite levels;	chr10:98415779	chr10:98395232~98395253:-
CESC	cis	rs950880	0.56	rs10183388	MIMAT0019927	hsa-miR-4772-3p	4.32	2.37e-05	0.26	0.28	Serum protein levels (sST2);	chr2:102315787	chr2:102432336~102432357:+
CESC	cis	rs9814567	1	rs9850015	MIMAT0019958	hsa-miR-4788	4.32	2.38e-05	0.35	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134550699	chr3:134437836~134437857:+
CESC	cis	rs9807989	0.839	rs4988957	MIMAT0019927	hsa-miR-4772-3p	4.32	2.41e-05	0.29	0.28	Asthma;	chr2:102351615	chr2:102432336~102432357:+
CESC	cis	rs1712517	0.873	rs1891292	MIMAT0005951	hsa-miR-1307-3p	4.32	2.42e-05	0.21	0.28	Migraine;	chr10:103241753	chr10:103394301~103394322:-
CESC	cis	rs7072216	0.763	rs7909822	MIMAT0005878	hsa-miR-1287-5p	4.31	2.45e-05	0.27	0.28	Metabolite levels;	chr10:98412278	chr10:98395271~98395292:-
CESC	cis	rs9814567	1	rs6785027	MIMAT0019958	hsa-miR-4788	-4.31	2.46e-05	-0.34	-0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134492807	chr3:134437836~134437857:+
CESC	cis	rs950880	0.645	rs56044378	MIMAT0019927	hsa-miR-4772-3p	4.31	2.49e-05	0.28	0.28	Serum protein levels (sST2);	chr2:102448907	chr2:102432336~102432357:+
CESC	cis	rs10021731	0.659	rs13105730	MIMAT0003242	hsa-miR-577	-4.31	2.51e-05	-0.29	-0.28	Optic disc area;	chr4:114490021	chr4:114656774~114656794:+
CESC	cis	rs4921799	0.662	rs7462063	MIMAT0015020	hsa-miR-548v	-4.31	2.52e-05	-0.33	-0.28	Lung cancer;Adenocarcinoma;	chr8:17678838	chr8:17681588~17681609:-
CESC	cis	rs1472147	0.955	rs3736614	MIMAT0000259	hsa-miR-182-5p	4.3	2.54e-05	0.29	0.28	Calcium levels;	chr7:128868994	chr7:129770447~129770470:-
CESC	cis	rs10021731	0.725	rs12502750	MIMAT0003242	hsa-miR-577	4.3	2.55e-05	0.3	0.28	Optic disc area;	chr4:114499194	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.725	rs7674990	MIMAT0003242	hsa-miR-577	4.3	2.57e-05	0.3	0.28	Optic disc area;	chr4:114506467	chr4:114656774~114656794:+
CESC	cis	rs9814567	1	rs62271514	MIMAT0019958	hsa-miR-4788	-4.3	2.59e-05	-0.35	-0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134579712	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs4423809	MIMAT0019958	hsa-miR-4788	-4.3	2.59e-05	-0.35	-0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134581265	chr3:134437836~134437857:+
CESC	cis	rs950880	0.553	rs3755272	MIMAT0019927	hsa-miR-4772-3p	4.3	2.62e-05	0.31	0.28	Serum protein levels (sST2);	chr2:102417365	chr2:102432336~102432357:+
CESC	cis	rs9814567	1	rs9289471	MIMAT0019958	hsa-miR-4788	4.3	2.62e-05	0.35	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134511969	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs4334685	MIMAT0019958	hsa-miR-4788	4.29	2.68e-05	0.35	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134585493	chr3:134437836~134437857:+
CESC	cis	rs950880	0.71	rs12470867	MIMAT0019927	hsa-miR-4772-3p	4.29	2.68e-05	0.3	0.28	Serum protein levels (sST2);	chr2:102309906	chr2:102432336~102432357:+
CESC	cis	rs1472147	0.955	rs3736614	MIMAT0000261	hsa-miR-183-5p	4.29	2.72e-05	0.26	0.28	Calcium levels;	chr7:128868994	chr7:129774967~129774988:-
CESC	cis	rs7072216	0.763	rs2147901	MIMAT0026738	hsa-miR-1287-3p	-4.28	2.77e-05	-0.25	-0.28	Metabolite levels;	chr10:98405739	chr10:98395232~98395253:-
CESC	cis	rs950880	0.56	rs1558619	MIMAT0019927	hsa-miR-4772-3p	4.28	2.82e-05	0.25	0.28	Serum protein levels (sST2);	chr2:102315090	chr2:102432336~102432357:+
CESC	cis	rs1163656	0.536	rs7306751	MIMAT0003287	hsa-miR-618	-4.28	2.82e-05	-0.37	-0.28	Dental caries;	chr12:80922459	chr12:80935796~80935818:-
CESC	cis	rs4921799	0.662	rs35211928	MIMAT0015020	hsa-miR-548v	-4.28	2.84e-05	-0.31	-0.28	Lung cancer;Adenocarcinoma;	chr8:17677494	chr8:17681588~17681609:-
CESC	cis	rs4921799	0.662	rs12680944	MIMAT0015020	hsa-miR-548v	-4.28	2.84e-05	-0.31	-0.28	Lung cancer;Adenocarcinoma;	chr8:17677530	chr8:17681588~17681609:-
CESC	cis	rs9814567	0.865	rs9834981	MIMAT0019958	hsa-miR-4788	4.27	2.86e-05	0.35	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134563437	chr3:134437836~134437857:+
CESC	cis	rs8026198	0.5	rs59974698	MIMAT0026623	hsa-miR-627-3p	4.27	2.89e-05	0.55	0.28	Fibrinogen levels;	chr15:42266082	chr15:42199593~42199612:-
CESC	cis	rs6841433	0.615	rs12642541	MIMAT0003242	hsa-miR-577	4.27	2.89e-05	0.38	0.28	Hemoglobin concentration;	chr4:114579576	chr4:114656774~114656794:+
CESC	cis	rs4921799	0.64	rs10112153	MIMAT0015020	hsa-miR-548v	-4.27	2.93e-05	-0.33	-0.28	Lung cancer;Adenocarcinoma;	chr8:17679023	chr8:17681588~17681609:-
CESC	cis	rs4921799	0.64	rs10109250	MIMAT0015020	hsa-miR-548v	-4.27	2.93e-05	-0.33	-0.28	Lung cancer;Adenocarcinoma;	chr8:17679026	chr8:17681588~17681609:-
CESC	cis	rs79387448	0.638	rs116055209	MIMAT0019926	hsa-miR-4772-5p	-4.27	2.95e-05	-0.5	-0.28	Gut microbiota (bacterial taxa);	chr2:102415729	chr2:102432300~102432321:+
CESC	cis	rs6841433	0.615	rs57930571	MIMAT0003242	hsa-miR-577	4.27	2.96e-05	0.38	0.28	Hemoglobin concentration;	chr4:114580433	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs35732213	MIMAT0003242	hsa-miR-577	4.27	2.96e-05	0.38	0.28	Hemoglobin concentration;	chr4:114581427	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs35936834	MIMAT0003242	hsa-miR-577	4.27	2.96e-05	0.38	0.28	Hemoglobin concentration;	chr4:114581520	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs6813229	MIMAT0003242	hsa-miR-577	4.27	2.96e-05	0.38	0.28	Hemoglobin concentration;	chr4:114582721	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs6813283	MIMAT0003242	hsa-miR-577	4.27	2.96e-05	0.38	0.28	Hemoglobin concentration;	chr4:114582806	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.571	rs6839189	MIMAT0003242	hsa-miR-577	4.27	2.96e-05	0.38	0.28	Hemoglobin concentration;	chr4:114582848	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.725	rs62309917	MIMAT0003242	hsa-miR-577	4.27	2.98e-05	0.3	0.28	Optic disc area;	chr4:114522432	chr4:114656774~114656794:+
CESC	cis	rs9814567	1	rs9854299	MIMAT0019958	hsa-miR-4788	4.26	2.99e-05	0.34	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134487886	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.896	rs6799110	MIMAT0019958	hsa-miR-4788	4.26	2.99e-05	0.34	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134487907	chr3:134437836~134437857:+
CESC	cis	rs10021731	0.521	rs116635794	MIMAT0003242	hsa-miR-577	-4.26	3.02e-05	-0.3	-0.28	Optic disc area;	chr4:114520865	chr4:114656774~114656794:+
CESC	cis	rs9814567	1	rs6806417	MIMAT0019958	hsa-miR-4788	-4.26	3.06e-05	-0.33	-0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134492604	chr3:134437836~134437857:+
CESC	cis	rs950880	0.56	rs1420102	MIMAT0019927	hsa-miR-4772-3p	4.26	3.08e-05	0.26	0.28	Serum protein levels (sST2);	chr2:102332359	chr2:102432336~102432357:+
CESC	cis	rs10021731	0.725	rs12641633	MIMAT0003242	hsa-miR-577	4.26	3.08e-05	0.29	0.28	Optic disc area;	chr4:114488186	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.725	rs4833457	MIMAT0003242	hsa-miR-577	4.26	3.08e-05	0.29	0.28	Optic disc area;	chr4:114490891	chr4:114656774~114656794:+
CESC	cis	rs7209460	0.556	rs2316513	MIMAT0004495	hsa-miR-22-5p	-4.25	3.13e-05	-0.26	-0.28	Coronary artery disease;Total body bone mineral density;	chr17:2085083	chr17:1713952~1713973:-
CESC	cis	rs9814567	0.896	rs11915964	MIMAT0019958	hsa-miR-4788	-4.25	3.15e-05	-0.35	-0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134630088	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs9968172	MIMAT0019958	hsa-miR-4788	-4.24	3.24e-05	-0.35	-0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134512409	chr3:134437836~134437857:+
CESC	cis	rs7072216	0.763	rs1061437	MIMAT0026738	hsa-miR-1287-3p	4.24	3.24e-05	0.25	0.28	Metabolite levels;	chr10:98416397	chr10:98395232~98395253:-
CESC	cis	rs1472147	1	rs13225751	MIMAT0000261	hsa-miR-183-5p	4.24	3.3e-05	0.26	0.28	Calcium levels;	chr7:128864475	chr7:129774967~129774988:-
CESC	cis	rs1472147	1	rs13226115	MIMAT0000261	hsa-miR-183-5p	4.24	3.3e-05	0.26	0.28	Calcium levels;	chr7:128864521	chr7:129774967~129774988:-
CESC	cis	rs10021731	0.725	rs13103327	MIMAT0003242	hsa-miR-577	4.24	3.31e-05	0.29	0.28	Optic disc area;	chr4:114532551	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.725	rs12503513	MIMAT0003242	hsa-miR-577	4.24	3.31e-05	0.29	0.28	Optic disc area;	chr4:114534996	chr4:114656774~114656794:+
CESC	cis	rs76886731	1	rs76886731	MIMAT0019927	hsa-miR-4772-3p	4.24	3.33e-05	0.26	0.28	Leprosy;	chr2:102328956	chr2:102432336~102432357:+
CESC	cis	rs9814567	1	rs6790466	MIMAT0019958	hsa-miR-4788	4.23	3.39e-05	0.35	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134478898	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs4498009	MIMAT0019958	hsa-miR-4788	4.23	3.39e-05	0.35	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134479166	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs9826496	MIMAT0019958	hsa-miR-4788	4.23	3.39e-05	0.34	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134505595	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs7432268	MIMAT0019958	hsa-miR-4788	4.23	3.41e-05	0.35	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134523209	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs1138273	MIMAT0019958	hsa-miR-4788	4.23	3.41e-05	0.35	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134542595	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs7427492	MIMAT0019958	hsa-miR-4788	4.23	3.41e-05	0.35	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134542812	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs9827987	MIMAT0019958	hsa-miR-4788	4.23	3.41e-05	0.35	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134553779	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs7374325	MIMAT0019958	hsa-miR-4788	4.23	3.41e-05	0.35	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134556759	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs2370578	MIMAT0019958	hsa-miR-4788	4.23	3.42e-05	0.35	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134480770	chr3:134437836~134437857:+
CESC	cis	rs10021731	0.725	rs7667556	MIMAT0003242	hsa-miR-577	4.23	3.42e-05	0.29	0.28	Optic disc area;	chr4:114535359	chr4:114656774~114656794:+
CESC	cis	rs950880	0.517	rs1420088	MIMAT0019927	hsa-miR-4772-3p	4.23	3.44e-05	0.26	0.28	Serum protein levels (sST2);	chr2:102322974	chr2:102432336~102432357:+
CESC	cis	rs950880	0.56	rs11123920	MIMAT0019927	hsa-miR-4772-3p	4.23	3.44e-05	0.26	0.28	Serum protein levels (sST2);	chr2:102323373	chr2:102432336~102432357:+
CESC	cis	rs950880	0.56	rs11676075	MIMAT0019927	hsa-miR-4772-3p	4.23	3.44e-05	0.26	0.28	Serum protein levels (sST2);	chr2:102324755	chr2:102432336~102432357:+
CESC	cis	rs950880	0.518	rs12996772	MIMAT0019927	hsa-miR-4772-3p	4.23	3.44e-05	0.26	0.28	Serum protein levels (sST2);	chr2:102330741	chr2:102432336~102432357:+
CESC	cis	rs453301	0.686	rs3989373	MIMAT0019728	hsa-miR-4660	-4.23	3.44e-05	-0.33	-0.28	Joint mobility (Beighton score);	chr8:9053798	chr8:9048453~9048475:+
CESC	cis	rs9814567	1	rs10804632	MIMAT0019958	hsa-miR-4788	4.23	3.45e-05	0.34	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134575659	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs4955485	MIMAT0019958	hsa-miR-4788	4.23	3.45e-05	0.34	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134577001	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs9864439	MIMAT0019958	hsa-miR-4788	4.23	3.45e-05	0.34	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134579829	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs62271515	MIMAT0019958	hsa-miR-4788	4.23	3.45e-05	0.34	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134581665	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs13322305	MIMAT0019958	hsa-miR-4788	4.23	3.45e-05	0.34	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134591949	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs7433991	MIMAT0019958	hsa-miR-4788	4.23	3.45e-05	0.34	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134593450	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs2056604	MIMAT0019958	hsa-miR-4788	4.23	3.45e-05	0.34	0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134593806	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs9814567	MIMAT0019958	hsa-miR-4788	-4.22	3.54e-05	-0.33	-0.28	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134499715	chr3:134437836~134437857:+
CESC	cis	rs453301	0.686	rs6748	MIMAT0019728	hsa-miR-4660	-4.22	3.59e-05	-0.34	-0.27	Joint mobility (Beighton score);	chr8:9033292	chr8:9048453~9048475:+
CESC	cis	rs11630316	1	rs11630316	MIMAT0004810	hsa-miR-629-5p	-4.22	3.62e-05	-0.27	-0.27	Cognitive function;	chr15:70077039	chr15:70079427~70079447:-
CESC	cis	rs7072216	0.843	rs4400721	MIMAT0005878	hsa-miR-1287-5p	4.22	3.66e-05	0.27	0.27	Metabolite levels;	chr10:98387340	chr10:98395271~98395292:-
CESC	cis	rs950880	1	rs12470864	MIMAT0019927	hsa-miR-4772-3p	4.21	3.69e-05	0.28	0.27	Serum protein levels (sST2);	chr2:102309902	chr2:102432336~102432357:+
CESC	cis	rs6841433	0.615	rs13144260	MIMAT0003242	hsa-miR-577	4.21	3.75e-05	0.37	0.27	Hemoglobin concentration;	chr4:114573271	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs34948407	MIMAT0003242	hsa-miR-577	4.21	3.75e-05	0.37	0.27	Hemoglobin concentration;	chr4:114575280	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs56149980	MIMAT0003242	hsa-miR-577	4.21	3.75e-05	0.37	0.27	Hemoglobin concentration;	chr4:114576580	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.571	rs17047238	MIMAT0003242	hsa-miR-577	4.2	3.81e-05	0.37	0.27	Hemoglobin concentration;	chr4:114568870	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.729	rs17047190	MIMAT0003242	hsa-miR-577	4.2	3.82e-05	0.29	0.27	Optic disc area;	chr4:114536699	chr4:114656774~114656794:+
CESC	cis	rs9807989	0.839	rs4988956	MIMAT0019927	hsa-miR-4772-3p	-4.2	3.83e-05	-0.29	-0.27	Asthma;	chr2:102351547	chr2:102432336~102432357:+
CESC	cis	rs75358501	0.688	rs2287629	MIMAT0014994	hsa-miR-3130-3p	-4.2	3.87e-05	-0.35	-0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783245~206783265:-
CESC	cis	rs75358501	0.688	rs2287629	MIMAT0014994_1	hsa-miR-3130-3p	-4.2	3.87e-05	-0.35	-0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783277~206783297:+
CESC	cis	rs4921799	0.597	rs35034557	MIMAT0015020	hsa-miR-548v	-4.2	3.87e-05	-0.32	-0.27	Lung cancer;Adenocarcinoma;	chr8:17679136	chr8:17681588~17681609:-
CESC	cis	rs4921799	0.686	rs10112397	MIMAT0015020	hsa-miR-548v	-4.2	3.87e-05	-0.32	-0.27	Lung cancer;Adenocarcinoma;	chr8:17679195	chr8:17681588~17681609:-
CESC	cis	rs4921799	0.513	rs10112412	MIMAT0015020	hsa-miR-548v	-4.2	3.87e-05	-0.32	-0.27	Lung cancer;Adenocarcinoma;	chr8:17679236	chr8:17681588~17681609:-
CESC	cis	rs4921799	0.577	rs10112413	MIMAT0015020	hsa-miR-548v	-4.2	3.87e-05	-0.32	-0.27	Lung cancer;Adenocarcinoma;	chr8:17679238	chr8:17681588~17681609:-
CESC	cis	rs9814567	1	rs9990351	MIMAT0019958	hsa-miR-4788	-4.2	3.9e-05	-0.33	-0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134520349	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs1917130	MIMAT0019958	hsa-miR-4788	-4.19	4e-05	-0.35	-0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134594931	chr3:134437836~134437857:+
CESC	cis	rs950880	0.71	rs2287035	MIMAT0019927	hsa-miR-4772-3p	4.19	4.06e-05	0.29	0.27	Serum protein levels (sST2);	chr2:102394070	chr2:102432336~102432357:+
CESC	cis	rs1163656	0.819	rs1185534	MIMAT0003287	hsa-miR-618	4.19	4.06e-05	0.36	0.27	Dental caries;	chr12:80944374	chr12:80935796~80935818:-
CESC	cis	rs9807989	0.765	rs13424006	MIMAT0019927	hsa-miR-4772-3p	-4.19	4.07e-05	-0.29	-0.27	Asthma;	chr2:102350776	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.765	rs6751967	MIMAT0019927	hsa-miR-4772-3p	-4.19	4.07e-05	-0.29	-0.27	Asthma;	chr2:102350953	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.765	rs6751977	MIMAT0019927	hsa-miR-4772-3p	-4.19	4.07e-05	-0.29	-0.27	Asthma;	chr2:102350970	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.765	rs6704565	MIMAT0019927	hsa-miR-4772-3p	-4.19	4.07e-05	-0.29	-0.27	Asthma;	chr2:102350971	chr2:102432336~102432357:+
CESC	cis	rs9814567	1	rs1814337	MIMAT0019958	hsa-miR-4788	4.18	4.17e-05	0.34	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134481840	chr3:134437836~134437857:+
CESC	cis	rs10021731	0.725	rs922199	MIMAT0003242	hsa-miR-577	-4.18	4.19e-05	-0.29	-0.27	Optic disc area;	chr4:114485362	chr4:114656774~114656794:+
CESC	cis	rs9807989	0.839	rs6749114	MIMAT0019927	hsa-miR-4772-3p	-4.18	4.2e-05	-0.29	-0.27	Asthma;	chr2:102351127	chr2:102432336~102432357:+
CESC	cis	rs6841433	0.615	rs79776742	MIMAT0003242	hsa-miR-577	4.18	4.27e-05	0.38	0.27	Hemoglobin concentration;	chr4:114550195	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs57059575	MIMAT0003242	hsa-miR-577	4.18	4.27e-05	0.38	0.27	Hemoglobin concentration;	chr4:114551237	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs13147106	MIMAT0003242	hsa-miR-577	4.18	4.27e-05	0.38	0.27	Hemoglobin concentration;	chr4:114552206	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs13147485	MIMAT0003242	hsa-miR-577	4.18	4.27e-05	0.38	0.27	Hemoglobin concentration;	chr4:114552321	chr4:114656774~114656794:+
CESC	cis	rs9807989	0.801	rs6734742	MIMAT0019927	hsa-miR-4772-3p	-4.18	4.28e-05	-0.29	-0.27	Asthma;	chr2:102351397	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.801	rs6752482	MIMAT0019927	hsa-miR-4772-3p	-4.18	4.28e-05	-0.29	-0.27	Asthma;	chr2:102351398	chr2:102432336~102432357:+
CESC	cis	rs950880	0.56	rs11690443	MIMAT0019927	hsa-miR-4772-3p	4.17	4.32e-05	0.25	0.27	Serum protein levels (sST2);	chr2:102319671	chr2:102432336~102432357:+
CESC	cis	rs950880	0.56	rs12712136	MIMAT0019927	hsa-miR-4772-3p	4.17	4.34e-05	0.25	0.27	Serum protein levels (sST2);	chr2:102319906	chr2:102432336~102432357:+
CESC	cis	rs9814567	1	rs9856693	MIMAT0019958	hsa-miR-4788	4.17	4.36e-05	0.34	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134588071	chr3:134437836~134437857:+
CESC	cis	rs8026198	0.568	rs12438509	MIMAT0026623	hsa-miR-627-3p	4.17	4.38e-05	0.54	0.27	Fibrinogen levels;	chr15:42258155	chr15:42199593~42199612:-
CESC	cis	rs6841433	0.615	rs35252674	MIMAT0003242	hsa-miR-577	4.17	4.4e-05	0.38	0.27	Hemoglobin concentration;	chr4:114556583	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs12641516	MIMAT0003242	hsa-miR-577	4.17	4.4e-05	0.38	0.27	Hemoglobin concentration;	chr4:114556972	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs71606719	MIMAT0003242	hsa-miR-577	4.17	4.4e-05	0.38	0.27	Hemoglobin concentration;	chr4:114557814	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.511	rs13125495	MIMAT0003242	hsa-miR-577	4.17	4.4e-05	0.38	0.27	Hemoglobin concentration;	chr4:114558326	chr4:114656774~114656794:+
CESC	cis	rs950880	0.71	rs1474309	MIMAT0019927	hsa-miR-4772-3p	-4.17	4.41e-05	-0.5	-0.27	Serum protein levels (sST2);	chr2:102474542	chr2:102432336~102432357:+
CESC	cis	rs8026198	0.568	rs57393446	MIMAT0026623	hsa-miR-627-3p	4.17	4.43e-05	0.54	0.27	Fibrinogen levels;	chr15:42202338	chr15:42199593~42199612:-
CESC	cis	rs1867631	1	rs11208927	MIMAT0014979	hsa-miR-3117-3p	-4.17	4.45e-05	-0.34	-0.27	Menopause (age at onset);	chr1:66623878	chr1:66628485~66628505:+
CESC	cis	rs9814567	1	rs9834755	MIMAT0019958	hsa-miR-4788	4.16	4.57e-05	0.34	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134488003	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs6772896	MIMAT0019958	hsa-miR-4788	4.16	4.62e-05	0.34	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134484505	chr3:134437836~134437857:+
CESC	cis	rs10021731	0.718	rs4409025	MIMAT0003242	hsa-miR-577	-4.16	4.62e-05	-0.29	-0.27	Optic disc area;	chr4:114511785	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs4409026	MIMAT0003242	hsa-miR-577	-4.16	4.62e-05	-0.29	-0.27	Optic disc area;	chr4:114511787	chr4:114656774~114656794:+
CESC	cis	rs1472147	0.955	rs3736614	MIMAT0000095	hsa-miR-96-5p	4.16	4.64e-05	0.28	0.27	Calcium levels;	chr7:128868994	chr7:129774739~129774761:-
CESC	cis	rs9807989	0.507	rs4851004	MIMAT0019927	hsa-miR-4772-3p	4.16	4.64e-05	0.27	0.27	Asthma;	chr2:102393077	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.839	rs10192036	MIMAT0019927	hsa-miR-4772-3p	-4.16	4.67e-05	-0.28	-0.27	Asthma;	chr2:102351751	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.839	rs10204137	MIMAT0019927	hsa-miR-4772-3p	-4.16	4.67e-05	-0.28	-0.27	Asthma;	chr2:102351752	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.839	rs4988958	MIMAT0019927	hsa-miR-4772-3p	-4.16	4.67e-05	-0.28	-0.27	Asthma;	chr2:102351825	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.839	rs10192157	MIMAT0019927	hsa-miR-4772-3p	-4.16	4.67e-05	-0.28	-0.27	Asthma;	chr2:102351896	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.839	rs10206753	MIMAT0019927	hsa-miR-4772-3p	-4.16	4.67e-05	-0.28	-0.27	Asthma;	chr2:102351902	chr2:102432336~102432357:+
CESC	cis	rs1867631	1	rs7546090	MIMAT0014979	hsa-miR-3117-3p	-4.15	4.68e-05	-0.34	-0.27	Menopause (age at onset);	chr1:66618298	chr1:66628485~66628505:+
CESC	cis	rs950880	0.56	rs4142132	MIMAT0019927	hsa-miR-4772-3p	4.15	4.74e-05	0.25	0.27	Serum protein levels (sST2);	chr2:102321022	chr2:102432336~102432357:+
CESC	cis	rs8026198	0.568	rs1659219	MIMAT0026623	hsa-miR-627-3p	4.15	4.76e-05	0.47	0.27	Fibrinogen levels;	chr15:42323294	chr15:42199593~42199612:-
CESC	cis	rs453301	0.686	rs2409120	MIMAT0019728	hsa-miR-4660	-4.15	4.76e-05	-0.33	-0.27	Joint mobility (Beighton score);	chr8:9025061	chr8:9048453~9048475:+
CESC	cis	rs79387448	0.626	rs80256362	MIMAT0019926	hsa-miR-4772-5p	-4.15	4.83e-05	-0.49	-0.27	Gut microbiota (bacterial taxa);	chr2:102409041	chr2:102432300~102432321:+
CESC	cis	rs739525	0.518	rs178268	MIMAT0004611	hsa-miR-185-3p	4.15	4.86e-05	0.19	0.27	Testicular germ cell tumor;	chr22:20975977	chr22:20033188~20033209:+
CESC	cis	rs9814567	0.896	rs58491661	MIMAT0019958	hsa-miR-4788	-4.14	4.88e-05	-0.34	-0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134636347	chr3:134437836~134437857:+
CESC	cis	rs7072216	0.763	rs10883092	MIMAT0005878	hsa-miR-1287-5p	4.14	4.88e-05	0.26	0.27	Metabolite levels;	chr10:98407519	chr10:98395271~98395292:-
CESC	cis	rs7072216	0.763	rs10883091	MIMAT0005878	hsa-miR-1287-5p	4.14	4.91e-05	0.26	0.27	Metabolite levels;	chr10:98407482	chr10:98395271~98395292:-
CESC	cis	rs9814567	1	rs7645295	MIMAT0019958	hsa-miR-4788	4.14	4.95e-05	0.34	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134588892	chr3:134437836~134437857:+
CESC	cis	rs950880	0.71	rs17027166	MIMAT0019927	hsa-miR-4772-3p	4.14	4.97e-05	0.31	0.27	Serum protein levels (sST2);	chr2:102438960	chr2:102432336~102432357:+
CESC	cis	rs10021731	0.691	rs6849064	MIMAT0003242	hsa-miR-577	-4.14	5e-05	-0.29	-0.27	Optic disc area;	chr4:114483807	chr4:114656774~114656794:+
CESC	cis	rs9814567	1	rs11706117	MIMAT0019958	hsa-miR-4788	4.14	5.04e-05	0.33	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134493684	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs9871305	MIMAT0019958	hsa-miR-4788	4.14	5.04e-05	0.33	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134494696	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.806	rs6799543	MIMAT0019958	hsa-miR-4788	4.14	5.04e-05	0.33	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134497297	chr3:134437836~134437857:+
CESC	cis	rs950880	0.961	rs13020553	MIMAT0019927	hsa-miR-4772-3p	4.13	5.22e-05	0.27	0.27	Serum protein levels (sST2);	chr2:102315366	chr2:102432336~102432357:+
CESC	cis	rs9814567	1	rs4974484	MIMAT0019958	hsa-miR-4788	4.13	5.25e-05	0.33	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134500177	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.964	rs9820150	MIMAT0019958	hsa-miR-4788	4.13	5.25e-05	0.33	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134504169	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.964	rs9820425	MIMAT0019958	hsa-miR-4788	4.13	5.25e-05	0.33	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134504176	chr3:134437836~134437857:+
CESC	cis	rs1867631	1	rs11208928	MIMAT0014979	hsa-miR-3117-3p	-4.12	5.28e-05	-0.34	-0.27	Menopause (age at onset);	chr1:66623879	chr1:66628485~66628505:+
CESC	cis	rs950880	0.542	rs953934	MIMAT0019927	hsa-miR-4772-3p	4.12	5.29e-05	0.25	0.27	Serum protein levels (sST2);	chr2:102315833	chr2:102432336~102432357:+
CESC	cis	rs8026198	0.568	rs4924644	MIMAT0026623	hsa-miR-627-3p	4.12	5.33e-05	0.49	0.27	Fibrinogen levels;	chr15:42256835	chr15:42199593~42199612:-
CESC	cis	rs9814567	1	rs9829092	MIMAT0019958	hsa-miR-4788	4.12	5.33e-05	0.34	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134511024	chr3:134437836~134437857:+
CESC	cis	rs8026198	0.568	rs73407403	MIMAT0026623	hsa-miR-627-3p	4.12	5.34e-05	0.54	0.27	Fibrinogen levels;	chr15:42199510	chr15:42199593~42199612:-
CESC	cis	rs10021731	0.659	rs28564476	MIMAT0003242	hsa-miR-577	-4.11	5.53e-05	-0.28	-0.27	Optic disc area;	chr4:114484592	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.668	rs66482879	MIMAT0003242	hsa-miR-577	-4.11	5.55e-05	-0.28	-0.27	Optic disc area;	chr4:114517522	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs28657376	MIMAT0003242	hsa-miR-577	-4.11	5.55e-05	-0.28	-0.27	Optic disc area;	chr4:114517650	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.668	rs7684322	MIMAT0003242	hsa-miR-577	-4.11	5.55e-05	-0.28	-0.27	Optic disc area;	chr4:114519788	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs12108520	MIMAT0003242	hsa-miR-577	-4.11	5.55e-05	-0.28	-0.27	Optic disc area;	chr4:114522087	chr4:114656774~114656794:+
CESC	cis	rs950880	0.553	rs2241116	MIMAT0019927	hsa-miR-4772-3p	4.11	5.55e-05	0.3	0.27	Serum protein levels (sST2);	chr2:102386805	chr2:102432336~102432357:+
CESC	cis	rs10021731	0.718	rs958771	MIMAT0003242	hsa-miR-577	-4.11	5.56e-05	-0.28	-0.27	Optic disc area;	chr4:114514506	chr4:114656774~114656794:+
CESC	cis	rs1712517	0.844	rs1163081	MIMAT0005951	hsa-miR-1307-3p	-4.11	5.56e-05	-0.2	-0.27	Migraine;	chr10:103270083	chr10:103394301~103394322:-
CESC	cis	rs6841433	0.615	rs10516604	MIMAT0003242	hsa-miR-577	4.11	5.57e-05	0.37	0.27	Hemoglobin concentration;	chr4:114546112	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs13135560	MIMAT0003242	hsa-miR-577	4.11	5.57e-05	0.37	0.27	Hemoglobin concentration;	chr4:114547331	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs35777558	MIMAT0003242	hsa-miR-577	4.11	5.57e-05	0.37	0.27	Hemoglobin concentration;	chr4:114548111	chr4:114656774~114656794:+
CESC	cis	rs9814567	1	rs6782563	MIMAT0019958	hsa-miR-4788	-4.11	5.59e-05	-0.34	-0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134577117	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs6793487	MIMAT0019958	hsa-miR-4788	-4.11	5.59e-05	-0.34	-0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134580584	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs7611611	MIMAT0019958	hsa-miR-4788	4.11	5.59e-05	0.34	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134589035	chr3:134437836~134437857:+
CESC	cis	rs10021731	0.718	rs2054305	MIMAT0003242	hsa-miR-577	-4.11	5.59e-05	-0.29	-0.27	Optic disc area;	chr4:114496175	chr4:114656774~114656794:+
CESC	cis	rs9807989	0.773	rs72823661	MIMAT0019927	hsa-miR-4772-3p	-4.11	5.63e-05	-0.28	-0.27	Asthma;	chr2:102352256	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.801	rs72823663	MIMAT0019927	hsa-miR-4772-3p	-4.11	5.63e-05	-0.28	-0.27	Asthma;	chr2:102352278	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.811	rs67088699	MIMAT0019927	hsa-miR-4772-3p	-4.11	5.63e-05	-0.28	-0.27	Asthma;	chr2:102352291	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.773	rs5010059	MIMAT0019927	hsa-miR-4772-3p	-4.11	5.63e-05	-0.28	-0.27	Asthma;	chr2:102352366	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.839	rs11695627	MIMAT0019927	hsa-miR-4772-3p	-4.11	5.63e-05	-0.28	-0.27	Asthma;	chr2:102353645	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.801	rs7558339	MIMAT0019927	hsa-miR-4772-3p	-4.11	5.63e-05	-0.28	-0.27	Asthma;	chr2:102353783	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.811	rs7608638	MIMAT0019927	hsa-miR-4772-3p	-4.11	5.63e-05	-0.28	-0.27	Asthma;	chr2:102353829	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.811	rs4485584	MIMAT0019927	hsa-miR-4772-3p	-4.11	5.63e-05	-0.28	-0.27	Asthma;	chr2:102354290	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.811	rs4485585	MIMAT0019927	hsa-miR-4772-3p	-4.11	5.63e-05	-0.28	-0.27	Asthma;	chr2:102354299	chr2:102432336~102432357:+
CESC	cis	rs9807989	1	rs9807989	MIMAT0019927	hsa-miR-4772-3p	-4.11	5.63e-05	-0.28	-0.27	Asthma;	chr2:102354740	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.839	rs9808453	MIMAT0019927	hsa-miR-4772-3p	-4.11	5.63e-05	-0.28	-0.27	Asthma;	chr2:102354846	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.839	rs4851565	MIMAT0019927	hsa-miR-4772-3p	-4.11	5.63e-05	-0.28	-0.27	Asthma;	chr2:102355021	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.765	rs9807962	MIMAT0019927	hsa-miR-4772-3p	-4.11	5.63e-05	-0.28	-0.27	Asthma;	chr2:102355204	chr2:102432336~102432357:+
CESC	cis	rs10021731	0.692	rs7690858	MIMAT0003242	hsa-miR-577	-4.11	5.66e-05	-0.28	-0.27	Optic disc area;	chr4:114511804	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs4295329	MIMAT0003242	hsa-miR-577	-4.11	5.67e-05	-0.28	-0.27	Optic disc area;	chr4:114511945	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs4413472	MIMAT0003242	hsa-miR-577	-4.11	5.67e-05	-0.28	-0.27	Optic disc area;	chr4:114512090	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs11936113	MIMAT0003242	hsa-miR-577	-4.11	5.67e-05	-0.28	-0.27	Optic disc area;	chr4:114512224	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs11936150	MIMAT0003242	hsa-miR-577	-4.11	5.67e-05	-0.28	-0.27	Optic disc area;	chr4:114512391	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.692	rs2199314	MIMAT0003242	hsa-miR-577	-4.11	5.67e-05	-0.28	-0.27	Optic disc area;	chr4:114513555	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs28736894	MIMAT0003242	hsa-miR-577	-4.11	5.67e-05	-0.28	-0.27	Optic disc area;	chr4:114514184	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs17622270	MIMAT0003242	hsa-miR-577	-4.11	5.67e-05	-0.28	-0.27	Optic disc area;	chr4:114514205	chr4:114656774~114656794:+
CESC	cis	rs1472147	1	rs67476247	MIMAT0000259	hsa-miR-182-5p	4.11	5.7e-05	0.28	0.27	Calcium levels;	chr7:128864734	chr7:129770447~129770470:-
CESC	cis	rs6841433	0.615	rs34685786	MIMAT0003242	hsa-miR-577	4.1	5.81e-05	0.37	0.27	Hemoglobin concentration;	chr4:114549280	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs13120552	MIMAT0003242	hsa-miR-577	4.1	5.81e-05	0.37	0.27	Hemoglobin concentration;	chr4:114552518	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs13101831	MIMAT0003242	hsa-miR-577	4.1	5.81e-05	0.37	0.27	Hemoglobin concentration;	chr4:114552771	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.66	rs13127941	MIMAT0003242	hsa-miR-577	4.1	5.81e-05	0.37	0.27	Hemoglobin concentration;	chr4:114553520	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs13147198	MIMAT0003242	hsa-miR-577	4.1	5.81e-05	0.37	0.27	Hemoglobin concentration;	chr4:114553935	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs35594431	MIMAT0003242	hsa-miR-577	4.1	5.81e-05	0.37	0.27	Hemoglobin concentration;	chr4:114554497	chr4:114656774~114656794:+
CESC	cis	rs6681460	0.546	rs1998716	MIMAT0014979	hsa-miR-3117-3p	-4.1	5.92e-05	-0.33	-0.27	Presence of antiphospholipid antibodies;	chr1:66651423	chr1:66628485~66628505:+
CESC	cis	rs17639215	0.55	rs4851003	MIMAT0019927	hsa-miR-4772-3p	-4.09	5.96e-05	-0.3	-0.27	Serum protein levels (sST2);	chr2:102292817	chr2:102432336~102432357:+
CESC	cis	rs6841433	0.615	rs34403145	MIMAT0003242	hsa-miR-577	4.09	5.98e-05	0.37	0.27	Hemoglobin concentration;	chr4:114554629	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs12643074	MIMAT0003242	hsa-miR-577	4.09	5.98e-05	0.37	0.27	Hemoglobin concentration;	chr4:114555226	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs2100783	MIMAT0003242	hsa-miR-577	4.09	5.98e-05	0.37	0.27	Hemoglobin concentration;	chr4:114555821	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs12650115	MIMAT0003242	hsa-miR-577	4.09	5.98e-05	0.37	0.27	Hemoglobin concentration;	chr4:114560232	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs12644238	MIMAT0003242	hsa-miR-577	4.09	5.98e-05	0.37	0.27	Hemoglobin concentration;	chr4:114560598	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.571	rs1903365	MIMAT0003242	hsa-miR-577	4.09	5.98e-05	0.37	0.27	Hemoglobin concentration;	chr4:114561897	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.692	rs10021252	MIMAT0003242	hsa-miR-577	-4.09	6.08e-05	-0.28	-0.27	Optic disc area;	chr4:114515190	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.692	rs12108281	MIMAT0003242	hsa-miR-577	-4.09	6.08e-05	-0.28	-0.27	Optic disc area;	chr4:114522147	chr4:114656774~114656794:+
CESC	cis	rs9814567	1	rs6765505	MIMAT0019958	hsa-miR-4788	4.09	6.11e-05	0.33	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134489290	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.964	rs6772406	MIMAT0019958	hsa-miR-4788	4.09	6.11e-05	0.33	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134491341	chr3:134437836~134437857:+
CESC	cis	rs1163656	0.536	rs4261347	MIMAT0003287	hsa-miR-618	-4.09	6.16e-05	-0.36	-0.27	Dental caries;	chr12:80921546	chr12:80935796~80935818:-
CESC	cis	rs9807989	0.507	rs2287033	MIMAT0019927	hsa-miR-4772-3p	4.09	6.19e-05	0.25	0.27	Asthma;	chr2:102394777	chr2:102432336~102432357:+
CESC	cis	rs10021731	0.692	rs28361366	MIMAT0003242	hsa-miR-577	-4.08	6.2e-05	-0.28	-0.27	Optic disc area;	chr4:114512809	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs28656197	MIMAT0003242	hsa-miR-577	-4.08	6.2e-05	-0.28	-0.27	Optic disc area;	chr4:114512821	chr4:114656774~114656794:+
CESC	cis	rs9814567	0.964	rs9833753	MIMAT0019958	hsa-miR-4788	4.08	6.24e-05	0.33	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134494823	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs17694011	MIMAT0019958	hsa-miR-4788	4.08	6.24e-05	0.33	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134495139	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs62269547	MIMAT0019958	hsa-miR-4788	4.08	6.24e-05	0.33	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134495200	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs6802654	MIMAT0019958	hsa-miR-4788	4.08	6.24e-05	0.33	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134498230	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs934093	MIMAT0019958	hsa-miR-4788	4.08	6.27e-05	0.34	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134477043	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.964	rs3856729	MIMAT0019958	hsa-miR-4788	4.08	6.34e-05	0.34	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134482083	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs2887797	MIMAT0019958	hsa-miR-4788	4.08	6.34e-05	0.34	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134483664	chr3:134437836~134437857:+
CESC	cis	rs950880	0.767	rs13001714	MIMAT0019927	hsa-miR-4772-3p	4.08	6.34e-05	0.26	0.27	Serum protein levels (sST2);	chr2:102344025	chr2:102432336~102432357:+
CESC	cis	rs1712517	0.838	rs1891293	MIMAT0005951	hsa-miR-1307-3p	4.08	6.39e-05	0.21	0.27	Migraine;	chr10:103242040	chr10:103394301~103394322:-
CESC	cis	rs10021731	0.718	rs993460	MIMAT0003242	hsa-miR-577	-4.08	6.44e-05	-0.28	-0.27	Optic disc area;	chr4:114510521	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.693	rs7686100	MIMAT0003242	hsa-miR-577	-4.08	6.44e-05	-0.28	-0.27	Optic disc area;	chr4:114511670	chr4:114656774~114656794:+
CESC	cis	rs453301	0.658	rs13271797	MIMAT0019728	hsa-miR-4660	-4.07	6.45e-05	-0.33	-0.27	Joint mobility (Beighton score);	chr8:9028444	chr8:9048453~9048475:+
CESC	cis	rs950880	1	rs950880	MIMAT0019927	hsa-miR-4772-3p	4.07	6.46e-05	0.27	0.27	Serum protein levels (sST2);	chr2:102316102	chr2:102432336~102432357:+
CESC	cis	rs8026198	0.568	rs6493033	MIMAT0026623	hsa-miR-627-3p	4.07	6.49e-05	0.51	0.27	Fibrinogen levels;	chr15:42279054	chr15:42199593~42199612:-
CESC	cis	rs8026198	0.568	rs8027016	MIMAT0026623	hsa-miR-627-3p	4.07	6.49e-05	0.51	0.27	Fibrinogen levels;	chr15:42279073	chr15:42199593~42199612:-
CESC	cis	rs9814567	1	rs2370641	MIMAT0019958	hsa-miR-4788	4.07	6.5e-05	0.32	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134503319	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.964	rs9815983	MIMAT0019958	hsa-miR-4788	4.07	6.5e-05	0.32	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134503665	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.964	rs12492930	MIMAT0019958	hsa-miR-4788	4.07	6.5e-05	0.32	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134503880	chr3:134437836~134437857:+
CESC	cis	rs10021731	0.692	rs13103833	MIMAT0003242	hsa-miR-577	-4.07	6.5e-05	-0.28	-0.27	Optic disc area;	chr4:114495414	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.692	rs7662125	MIMAT0003242	hsa-miR-577	-4.07	6.5e-05	-0.28	-0.27	Optic disc area;	chr4:114495706	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs7689158	MIMAT0003242	hsa-miR-577	-4.07	6.5e-05	-0.28	-0.27	Optic disc area;	chr4:114495770	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.692	rs2054303	MIMAT0003242	hsa-miR-577	-4.07	6.5e-05	-0.28	-0.27	Optic disc area;	chr4:114495803	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs2054304	MIMAT0003242	hsa-miR-577	-4.07	6.5e-05	-0.28	-0.27	Optic disc area;	chr4:114495902	chr4:114656774~114656794:+
CESC	cis	rs950880	0.71	rs11693204	MIMAT0019927	hsa-miR-4772-3p	4.07	6.51e-05	0.28	0.27	Serum protein levels (sST2);	chr2:102319514	chr2:102432336~102432357:+
CESC	cis	rs10021731	0.718	rs2054306	MIMAT0003242	hsa-miR-577	-4.07	6.56e-05	-0.28	-0.27	Optic disc area;	chr4:114496204	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs2035059	MIMAT0003242	hsa-miR-577	-4.07	6.56e-05	-0.28	-0.27	Optic disc area;	chr4:114496530	chr4:114656774~114656794:+
CESC	cis	rs9814567	0.929	rs13316205	MIMAT0019958	hsa-miR-4788	4.06	6.72e-05	0.33	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134504721	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs11708531	MIMAT0019958	hsa-miR-4788	4.06	6.72e-05	0.33	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134506060	chr3:134437836~134437857:+
CESC	cis	rs10021731	0.693	rs114243292	MIMAT0003242	hsa-miR-577	-4.06	6.76e-05	-0.28	-0.27	Optic disc area;	chr4:114516751	chr4:114656774~114656794:+
CESC	cis	rs7072216	0.727	rs7915108	MIMAT0026738	hsa-miR-1287-3p	4.06	6.8e-05	0.25	0.27	Metabolite levels;	chr10:98404684	chr10:98395232~98395253:-
CESC	cis	rs7072216	0.727	rs7901577	MIMAT0026738	hsa-miR-1287-3p	4.06	6.8e-05	0.25	0.27	Metabolite levels;	chr10:98404685	chr10:98395232~98395253:-
CESC	cis	rs9814567	1	rs9813774	MIMAT0019958	hsa-miR-4788	4.06	6.82e-05	0.33	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134508258	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs3846056	MIMAT0019958	hsa-miR-4788	4.06	6.82e-05	0.33	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134508450	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs6804770	MIMAT0019958	hsa-miR-4788	4.06	6.82e-05	0.33	0.27	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134511392	chr3:134437836~134437857:+
CESC	cis	rs4921799	0.64	rs11990915	MIMAT0015020	hsa-miR-548v	-4.06	6.9e-05	-0.3	-0.27	Lung cancer;Adenocarcinoma;	chr8:17667519	chr8:17681588~17681609:-
CESC	cis	rs9814567	0.896	rs13089566	MIMAT0019958	hsa-miR-4788	-4.06	6.91e-05	-0.33	-0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134630868	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.896	rs6763188	MIMAT0019958	hsa-miR-4788	-4.06	6.91e-05	-0.33	-0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134631153	chr3:134437836~134437857:+
CESC	cis	rs1472147	0.955	rs3736611	MIMAT0000095	hsa-miR-96-5p	4.06	6.96e-05	0.27	0.26	Calcium levels;	chr7:128869189	chr7:129774739~129774761:-
CESC	cis	rs1867631	0.958	rs7520226	MIMAT0014979	hsa-miR-3117-3p	-4.05	7.02e-05	-0.33	-0.26	Menopause (age at onset);	chr1:66615312	chr1:66628485~66628505:+
CESC	cis	rs950880	1	rs12479210	MIMAT0019927	hsa-miR-4772-3p	4.05	7.11e-05	0.27	0.26	Serum protein levels (sST2);	chr2:102332701	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.801	rs4851566	MIMAT0019927	hsa-miR-4772-3p	-4.05	7.12e-05	-0.27	-0.26	Asthma;	chr2:102356339	chr2:102432336~102432357:+
CESC	cis	rs10021731	0.668	rs1599317	MIMAT0003242	hsa-miR-577	-4.05	7.12e-05	-0.28	-0.26	Optic disc area;	chr4:114503010	chr4:114656774~114656794:+
CESC	cis	rs4921799	0.662	rs3862096	MIMAT0015020	hsa-miR-548v	-4.05	7.17e-05	-0.31	-0.26	Lung cancer;Adenocarcinoma;	chr8:17686707	chr8:17681588~17681609:-
CESC	cis	rs10021731	0.725	rs6850121	MIMAT0003242	hsa-miR-577	-4.05	7.21e-05	-0.28	-0.26	Optic disc area;	chr4:114484294	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs7698790	MIMAT0003242	hsa-miR-577	4.05	7.23e-05	0.28	0.26	Optic disc area;	chr4:114492647	chr4:114656774~114656794:+
CESC	cis	rs9814567	1	rs9289476	MIMAT0019958	hsa-miR-4788	4.05	7.23e-05	0.33	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134518261	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.963	rs9844537	MIMAT0019958	hsa-miR-4788	4.05	7.23e-05	0.33	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134519499	chr3:134437836~134437857:+
CESC	cis	rs4790312	0.875	rs9303241	MIMAT0004495	hsa-miR-22-5p	-4.04	7.3e-05	-0.21	-0.26	Left atrial antero-posterior diameter;	chr17:2075669	chr17:1713952~1713973:-
CESC	cis	rs1712517	0.873	rs1712516	MIMAT0005951	hsa-miR-1307-3p	-4.04	7.37e-05	-0.21	-0.26	Migraine;	chr10:103273871	chr10:103394301~103394322:-
CESC	cis	rs6841433	0.615	rs17047239	MIMAT0003242	hsa-miR-577	4.04	7.42e-05	0.36	0.26	Hemoglobin concentration;	chr4:114570559	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.571	rs17047244	MIMAT0003242	hsa-miR-577	4.04	7.42e-05	0.36	0.26	Hemoglobin concentration;	chr4:114571532	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs17047246	MIMAT0003242	hsa-miR-577	4.04	7.42e-05	0.36	0.26	Hemoglobin concentration;	chr4:114571876	chr4:114656774~114656794:+
CESC	cis	rs950880	0.56	rs6733174	MIMAT0019927	hsa-miR-4772-3p	4.04	7.43e-05	0.24	0.26	Serum protein levels (sST2);	chr2:102312552	chr2:102432336~102432357:+
CESC	cis	rs3087591	1	rs2525578	MIMAT0022834	hsa-miR-365b-3p	4.04	7.56e-05	0.25	0.26	Hip circumference;	chr17:31384393	chr17:31575478~31575499:+
CESC	cis	rs6841433	0.615	rs13127912	MIMAT0003242	hsa-miR-577	4.03	7.56e-05	0.37	0.26	Hemoglobin concentration;	chr4:114546019	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs10516603	MIMAT0003242	hsa-miR-577	4.03	7.56e-05	0.37	0.26	Hemoglobin concentration;	chr4:114546303	chr4:114656774~114656794:+
CESC	cis	rs9807989	0.507	rs6758936	MIMAT0019927	hsa-miR-4772-3p	4.03	7.56e-05	0.26	0.26	Asthma;	chr2:102374909	chr2:102432336~102432357:+
CESC	cis	rs10021731	0.692	rs6834235	MIMAT0003242	hsa-miR-577	-4.03	7.57e-05	-0.27	-0.26	Optic disc area;	chr4:114531582	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs1599320	MIMAT0003242	hsa-miR-577	-4.03	7.57e-05	-0.27	-0.26	Optic disc area;	chr4:114532227	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs2126028	MIMAT0003242	hsa-miR-577	-4.03	7.57e-05	-0.27	-0.26	Optic disc area;	chr4:114533453	chr4:114656774~114656794:+
CESC	cis	rs4790312	0.935	rs3865240	MIMAT0004495	hsa-miR-22-5p	-4.03	7.64e-05	-0.24	-0.26	Left atrial antero-posterior diameter;	chr17:2088166	chr17:1713952~1713973:-
CESC	cis	rs6841433	0.615	rs79261962	MIMAT0003242	hsa-miR-577	4.03	7.64e-05	0.37	0.26	Hemoglobin concentration;	chr4:114539953	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs77422558	MIMAT0003242	hsa-miR-577	4.03	7.64e-05	0.37	0.26	Hemoglobin concentration;	chr4:114540944	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.571	rs12649041	MIMAT0003242	hsa-miR-577	4.03	7.64e-05	0.37	0.26	Hemoglobin concentration;	chr4:114541220	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs12649963	MIMAT0003242	hsa-miR-577	4.03	7.64e-05	0.37	0.26	Hemoglobin concentration;	chr4:114542537	chr4:114656774~114656794:+
CESC	cis	rs9814567	1	rs1874883	MIMAT0019958	hsa-miR-4788	4.03	7.66e-05	0.33	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134486229	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.929	rs1863912	MIMAT0019958	hsa-miR-4788	4.03	7.66e-05	0.33	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134486385	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.929	rs1863911	MIMAT0019958	hsa-miR-4788	4.03	7.66e-05	0.33	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134486389	chr3:134437836~134437857:+
CESC	cis	rs4790312	0.905	rs4790870	MIMAT0004495	hsa-miR-22-5p	-4.03	7.68e-05	-0.21	-0.26	Left atrial antero-posterior diameter;	chr17:2066907	chr17:1713952~1713973:-
CESC	cis	rs8026198	0.568	rs16972776	MIMAT0026623	hsa-miR-627-3p	4.03	7.7e-05	0.49	0.26	Fibrinogen levels;	chr15:42159815	chr15:42199593~42199612:-
CESC	cis	rs1163656	0.819	rs1795515	MIMAT0003287	hsa-miR-618	4.03	7.74e-05	0.35	0.26	Dental caries;	chr12:80941888	chr12:80935796~80935818:-
CESC	cis	rs79387448	0.638	rs76255660	MIMAT0019926	hsa-miR-4772-5p	-4.03	7.83e-05	-0.47	-0.26	Gut microbiota (bacterial taxa);	chr2:102474569	chr2:102432300~102432321:+
CESC	cis	rs9814567	1	rs9864346	MIMAT0019958	hsa-miR-4788	4.02	7.91e-05	0.33	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134593510	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs2056603	MIMAT0019958	hsa-miR-4788	4.02	7.91e-05	0.33	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134593907	chr3:134437836~134437857:+
CESC	cis	rs10021731	0.718	rs1585447	MIMAT0003242	hsa-miR-577	-4.02	7.94e-05	-0.28	-0.26	Optic disc area;	chr4:114490912	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs2199312	MIMAT0003242	hsa-miR-577	-4.02	7.98e-05	-0.28	-0.26	Optic disc area;	chr4:114513322	chr4:114656774~114656794:+
CESC	cis	rs453301	0.686	rs4840389	MIMAT0019728	hsa-miR-4660	-4.02	7.99e-05	-0.33	-0.26	Joint mobility (Beighton score);	chr8:9026993	chr8:9048453~9048475:+
CESC	cis	rs9814567	1	rs9989967	MIMAT0019958	hsa-miR-4788	4.02	8.01e-05	0.33	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134520122	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs9883753	MIMAT0019958	hsa-miR-4788	4.02	8.01e-05	0.33	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134528389	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs6801596	MIMAT0019958	hsa-miR-4788	4.02	8.01e-05	0.33	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134533272	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs9289478	MIMAT0019958	hsa-miR-4788	4.02	8.01e-05	0.33	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134549777	chr3:134437836~134437857:+
CESC	cis	rs950880	0.56	rs10189711	MIMAT0019927	hsa-miR-4772-3p	4.02	8.04e-05	0.24	0.26	Serum protein levels (sST2);	chr2:102314421	chr2:102432336~102432357:+
CESC	cis	rs10021731	0.692	rs13105714	MIMAT0003242	hsa-miR-577	-4.02	8.06e-05	-0.28	-0.26	Optic disc area;	chr4:114511171	chr4:114656774~114656794:+
CESC	cis	rs4790312	0.935	rs3744274	MIMAT0004495	hsa-miR-22-5p	-4.02	8.12e-05	-0.24	-0.26	Left atrial antero-posterior diameter;	chr17:2087665	chr17:1713952~1713973:-
CESC	cis	rs9814567	1	rs1814336	MIMAT0019958	hsa-miR-4788	4.02	8.17e-05	0.33	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134481981	chr3:134437836~134437857:+
CESC	cis	rs6841433	0.615	rs17047198	MIMAT0003242	hsa-miR-577	4.01	8.2e-05	0.37	0.26	Hemoglobin concentration;	chr4:114544338	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs17047201	MIMAT0003242	hsa-miR-577	4.01	8.2e-05	0.37	0.26	Hemoglobin concentration;	chr4:114544945	chr4:114656774~114656794:+
CESC	cis	rs9807989	0.507	rs7584093	MIMAT0019927	hsa-miR-4772-3p	-4.01	8.2e-05	-0.25	-0.26	Asthma;	chr2:102381261	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.507	rs3213732	MIMAT0019927	hsa-miR-4772-3p	-4.01	8.2e-05	-0.25	-0.26	Asthma;	chr2:102381819	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.507	rs10204757	MIMAT0019927	hsa-miR-4772-3p	-4.01	8.2e-05	-0.25	-0.26	Asthma;	chr2:102382514	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.524	rs7591246	MIMAT0019927	hsa-miR-4772-3p	-4.01	8.2e-05	-0.25	-0.26	Asthma;	chr2:102382943	chr2:102432336~102432357:+
CESC	cis	rs4988958	0.565	rs6760621	MIMAT0019927	hsa-miR-4772-3p	-4.01	8.2e-05	-0.25	-0.26	Asthma (childhood onset);	chr2:102383492	chr2:102432336~102432357:+
CESC	cis	rs4988958	0.527	rs11465641	MIMAT0019927	hsa-miR-4772-3p	-4.01	8.2e-05	-0.25	-0.26	Asthma (childhood onset);	chr2:102384408	chr2:102432336~102432357:+
CESC	cis	rs1867631	0.876	rs10889637	MIMAT0014979	hsa-miR-3117-3p	-4.01	8.22e-05	-0.33	-0.26	Menopause (age at onset);	chr1:66631782	chr1:66628485~66628505:+
CESC	cis	rs453301	0.653	rs1045529	MIMAT0019728	hsa-miR-4660	-4.01	8.23e-05	-0.32	-0.26	Joint mobility (Beighton score);	chr8:9032588	chr8:9048453~9048475:+
CESC	cis	rs4790312	0.729	rs9906546	MIMAT0004495	hsa-miR-22-5p	-4.01	8.23e-05	-0.21	-0.26	Left atrial antero-posterior diameter;	chr17:2092320	chr17:1713952~1713973:-
CESC	cis	rs1472147	1	rs67476247	MIMAT0000261	hsa-miR-183-5p	4.01	8.25e-05	0.25	0.26	Calcium levels;	chr7:128864734	chr7:129774967~129774988:-
CESC	cis	rs9807989	0.507	rs10208196	MIMAT0019927	hsa-miR-4772-3p	-4.01	8.32e-05	-0.25	-0.26	Asthma;	chr2:102379885	chr2:102432336~102432357:+
CESC	cis	rs7216064	0.953	rs62086044	MIMAT0003323	hsa-miR-548d-3p	4	8.54e-05	0.37	0.26	EGFR mutation-positive lung adenocarcinoma;Lung adenocarcinoma;Lung cancer;	chr17:67974721	chr17:67471504~67471525:-
CESC	cis	rs7216064	0.953	rs62086044	MIMAT0003323_1	hsa-miR-548d-3p	4	8.54e-05	0.37	0.26	EGFR mutation-positive lung adenocarcinoma;Lung adenocarcinoma;Lung cancer;	chr17:67974721	chr8:123348049~123348070:-
CESC	cis	rs950880	0.767	rs12712142	MIMAT0019927	hsa-miR-4772-3p	-4	8.57e-05	-0.26	-0.26	Serum protein levels (sST2);	chr2:102344124	chr2:102432336~102432357:+
CESC	cis	rs1163656	0.819	rs1716537	MIMAT0003287	hsa-miR-618	4	8.68e-05	0.34	0.26	Dental caries;	chr12:80940959	chr12:80935796~80935818:-
CESC	cis	rs950880	1	rs13019081	MIMAT0019927	hsa-miR-4772-3p	-4	8.68e-05	-0.27	-0.26	Serum protein levels (sST2);	chr2:102334362	chr2:102432336~102432357:+
CESC	cis	rs6976053	0.518	rs314353	MIMAT0000680	hsa-miR-106b-5p	4	8.7e-05	0.15	0.26	Plasminogen activator inhibitor type 1 levels (PAI-1);	chr7:100808522	chr7:100094043~100094063:-
CESC	cis	rs9814567	1	rs1357762	MIMAT0019958	hsa-miR-4788	4	8.71e-05	0.32	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134546017	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.896	rs4435682	MIMAT0019958	hsa-miR-4788	-4	8.8e-05	-0.33	-0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134625340	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.896	rs6790338	MIMAT0019958	hsa-miR-4788	3.99	8.91e-05	0.32	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134489325	chr3:134437836~134437857:+
CESC	cis	rs8064299	0.967	rs880827	MIMAT0017994	hsa-miR-3615	3.99	8.93e-05	0.26	0.26	Monocyte count;	chr17:74771296	chr17:74748663~74748683:+
CESC	cis	rs8064299	0.967	rs878906	MIMAT0017994	hsa-miR-3615	-3.99	9.01e-05	-0.26	-0.26	Monocyte count;	chr17:74773195	chr17:74748663~74748683:+
CESC	cis	rs8064299	0.967	rs878905	MIMAT0017994	hsa-miR-3615	-3.99	9.01e-05	-0.26	-0.26	Monocyte count;	chr17:74773272	chr17:74748663~74748683:+
CESC	cis	rs8064299	0.967	rs878907	MIMAT0017994	hsa-miR-3615	-3.99	9.01e-05	-0.26	-0.26	Monocyte count;	chr17:74773555	chr17:74748663~74748683:+
CESC	cis	rs9814567	1	rs6766897	MIMAT0019958	hsa-miR-4788	3.99	9.01e-05	0.32	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134472461	chr3:134437836~134437857:+
CESC	cis	rs6841433	0.615	rs7434753	MIMAT0003242	hsa-miR-577	3.99	9.03e-05	0.36	0.26	Hemoglobin concentration;	chr4:114596387	chr4:114656774~114656794:+
CESC	cis	rs9814567	1	rs9832785	MIMAT0019958	hsa-miR-4788	3.99	9.06e-05	0.32	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134494228	chr3:134437836~134437857:+
CESC	cis	rs1867631	1	rs10889636	MIMAT0014979	hsa-miR-3117-3p	3.99	9.08e-05	0.33	0.26	Menopause (age at onset);	chr1:66624241	chr1:66628485~66628505:+
CESC	cis	rs8026198	0.568	rs16973008	MIMAT0026623	hsa-miR-627-3p	-3.99	9.09e-05	-0.49	-0.26	Fibrinogen levels;	chr15:42287786	chr15:42199593~42199612:-
CESC	cis	rs1472147	0.955	rs3736611	MIMAT0000261	hsa-miR-183-5p	3.99	9.1e-05	0.25	0.26	Calcium levels;	chr7:128869189	chr7:129774967~129774988:-
CESC	cis	rs7649443	0.788	rs13070238	MIMAT0019973	hsa-miR-4797-3p	3.98	9.29e-05	0.31	0.26	Nonsyndromic cleft lip with cleft palate;	chr3:197229496	chr3:197293888~197293908:-
CESC	cis	rs9814567	0.896	rs1357764	MIMAT0019958	hsa-miR-4788	-3.98	9.29e-05	-0.33	-0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134626086	chr3:134437836~134437857:+
CESC	cis	rs6841433	0.615	rs1380932	MIMAT0003242	hsa-miR-577	3.98	9.33e-05	0.35	0.26	Hemoglobin concentration;	chr4:114565923	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs35082726	MIMAT0003242	hsa-miR-577	3.98	9.33e-05	0.35	0.26	Hemoglobin concentration;	chr4:114566777	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.692	rs4409027	MIMAT0003242	hsa-miR-577	-3.98	9.34e-05	-0.28	-0.26	Optic disc area;	chr4:114511985	chr4:114656774~114656794:+
CESC	cis	rs9814567	1	rs4974493	MIMAT0019958	hsa-miR-4788	3.98	9.42e-05	0.32	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134501151	chr3:134437836~134437857:+
CESC	cis	rs9814567	1	rs2370642	MIMAT0019958	hsa-miR-4788	3.98	9.42e-05	0.32	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134503294	chr3:134437836~134437857:+
CESC	cis	rs9807989	0.507	rs11465721	MIMAT0019927	hsa-miR-4772-3p	-3.98	9.43e-05	-0.26	-0.26	Asthma;	chr2:102446780	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.507	rs2041739	MIMAT0019927	hsa-miR-4772-3p	3.98	9.43e-05	0.25	0.26	Asthma;	chr2:102377873	chr2:102432336~102432357:+
CESC	cis	rs1163656	0.572	rs1402348	MIMAT0003287	hsa-miR-618	-3.98	9.51e-05	-0.35	-0.26	Dental caries;	chr12:80919695	chr12:80935796~80935818:-
CESC	cis	rs1472147	0.955	rs3736611	MIMAT0000259	hsa-miR-182-5p	3.98	9.53e-05	0.27	0.26	Calcium levels;	chr7:128869189	chr7:129770447~129770470:-
CESC	cis	rs8050755	0.764	rs2516734	MIMAT0019221	hsa-miR-3677-5p	-3.98	9.55e-05	-0.41	-0.26	Major depressive disorder;	chr16:2055334	chr16:2270715~2270736:+
CESC	cis	rs9814567	0.964	rs4539979	MIMAT0019958	hsa-miR-4788	3.97	9.58e-05	0.33	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134568755	chr3:134437836~134437857:+
CESC	cis	rs9807989	0.524	rs6543126	MIMAT0019927	hsa-miR-4772-3p	-3.97	9.58e-05	-0.25	-0.26	Asthma;	chr2:102410644	chr2:102432336~102432357:+
CESC	cis	rs8026198	0.568	rs73398938	MIMAT0026623	hsa-miR-627-3p	3.97	9.59e-05	0.5	0.26	Fibrinogen levels;	chr15:42298375	chr15:42199593~42199612:-
CESC	cis	rs79387448	0.638	rs11465698	MIMAT0019926	hsa-miR-4772-5p	-3.97	9.6e-05	-0.48	-0.26	Gut microbiota (bacterial taxa);	chr2:102438117	chr2:102432300~102432321:+
CESC	cis	rs10021731	0.718	rs13104656	MIMAT0003242	hsa-miR-577	-3.97	9.6e-05	-0.28	-0.26	Optic disc area;	chr4:114495547	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.692	rs13104685	MIMAT0003242	hsa-miR-577	-3.97	9.6e-05	-0.28	-0.26	Optic disc area;	chr4:114495590	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.692	rs13104693	MIMAT0003242	hsa-miR-577	-3.97	9.6e-05	-0.28	-0.26	Optic disc area;	chr4:114495600	chr4:114656774~114656794:+
CESC	cis	rs4965121	0.564	rs2130882	MIMAT0019823	hsa-miR-4714-3p	-3.97	9.74e-05	-0.29	-0.26	Neuroticism;	chr15:97970615	chr15:98784473~98784494:+
CESC	cis	rs9814567	1	rs12490835	MIMAT0019958	hsa-miR-4788	3.97	9.75e-05	0.32	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134504888	chr3:134437836~134437857:+
CESC	cis	rs10021731	0.718	rs1824490	MIMAT0003242	hsa-miR-577	3.97	9.83e-05	0.27	0.26	Optic disc area;	chr4:114529766	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs1824489	MIMAT0003242	hsa-miR-577	3.97	9.83e-05	0.27	0.26	Optic disc area;	chr4:114529776	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs7669767	MIMAT0003242	hsa-miR-577	3.97	9.83e-05	0.27	0.26	Optic disc area;	chr4:114530264	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs2100782	MIMAT0003242	hsa-miR-577	3.97	9.83e-05	0.27	0.26	Optic disc area;	chr4:114530452	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs12508960	MIMAT0003242	hsa-miR-577	3.97	9.83e-05	0.27	0.26	Optic disc area;	chr4:114531061	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.681	rs11098254	MIMAT0003242	hsa-miR-577	3.97	9.83e-05	0.27	0.26	Optic disc area;	chr4:114531300	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs11098255	MIMAT0003242	hsa-miR-577	3.97	9.83e-05	0.27	0.26	Optic disc area;	chr4:114531393	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs7683270	MIMAT0003242	hsa-miR-577	3.97	9.83e-05	0.27	0.26	Optic disc area;	chr4:114532438	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs13103719	MIMAT0003242	hsa-miR-577	3.97	9.83e-05	0.27	0.26	Optic disc area;	chr4:114532620	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.681	rs13109008	MIMAT0003242	hsa-miR-577	3.97	9.83e-05	0.27	0.26	Optic disc area;	chr4:114532769	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs13109803	MIMAT0003242	hsa-miR-577	3.97	9.83e-05	0.27	0.26	Optic disc area;	chr4:114532837	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs7440658	MIMAT0003242	hsa-miR-577	3.97	9.83e-05	0.27	0.26	Optic disc area;	chr4:114533303	chr4:114656774~114656794:+
CESC	cis	rs950880	0.542	rs12712135	MIMAT0019927	hsa-miR-4772-3p	3.97	9.84e-05	0.23	0.26	Serum protein levels (sST2);	chr2:102314488	chr2:102432336~102432357:+
CESC	cis	rs9814567	1	rs6766818	MIMAT0019958	hsa-miR-4788	3.97	9.89e-05	0.32	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134507317	chr3:134437836~134437857:+
CESC	cis	rs10021731	0.718	rs13117126	MIMAT0003242	hsa-miR-577	-3.97	9.9e-05	-0.27	-0.26	Optic disc area;	chr4:114526758	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs10857032	MIMAT0003242	hsa-miR-577	-3.97	9.92e-05	-0.27	-0.26	Optic disc area;	chr4:114527831	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.631	rs11098253	MIMAT0003242	hsa-miR-577	-3.97	9.92e-05	-0.27	-0.26	Optic disc area;	chr4:114527990	chr4:114656774~114656794:+
CESC	cis	rs950880	0.767	rs6543119	MIMAT0019927	hsa-miR-4772-3p	3.97	9.92e-05	0.25	0.26	Serum protein levels (sST2);	chr2:102346612	chr2:102432336~102432357:+
CESC	cis	rs950880	0.767	rs13017455	MIMAT0019927	hsa-miR-4772-3p	3.97	9.92e-05	0.25	0.26	Serum protein levels (sST2);	chr2:102348282	chr2:102432336~102432357:+
CESC	cis	rs343496	0.877	rs340933	MIMAT0019739	hsa-miR-4665-5p	3.97	9.94e-05	0.39	0.26	Asthma and hay fever;	chr9:6085078	chr9:6007835~6007857:+
CESC	cis	rs10021731	0.725	rs72676244	MIMAT0003242	hsa-miR-577	3.96	0.000101	0.28	0.26	Optic disc area;	chr4:114479168	chr4:114656774~114656794:+
CESC	cis	rs3771180	0.505	rs2160203	MIMAT0019926	hsa-miR-4772-5p	3.96	0.000102	0.35	0.26	Asthma;	chr2:102344364	chr2:102432300~102432321:+
CESC	cis	rs950880	0.542	rs1558621	MIMAT0019927	hsa-miR-4772-3p	3.96	0.000102	0.23	0.26	Serum protein levels (sST2);	chr2:102313847	chr2:102432336~102432357:+
CESC	cis	rs6841433	0.615	rs13136602	MIMAT0003242	hsa-miR-577	3.96	0.000103	0.36	0.26	Hemoglobin concentration;	chr4:114541864	chr4:114656774~114656794:+
CESC	cis	rs6841433	0.615	rs12649943	MIMAT0003242	hsa-miR-577	3.96	0.000103	0.36	0.26	Hemoglobin concentration;	chr4:114542460	chr4:114656774~114656794:+
CESC	cis	rs453301	0.624	rs2979265	MIMAT0019728	hsa-miR-4660	3.96	0.000103	0.3	0.26	Joint mobility (Beighton score);	chr8:9001207	chr8:9048453~9048475:+
CESC	cis	rs6841433	0.615	rs17047236	MIMAT0003242	hsa-miR-577	3.95	0.000104	0.35	0.26	Hemoglobin concentration;	chr4:114564575	chr4:114656774~114656794:+
CESC	cis	rs1712517	0.771	rs10883857	MIMAT0005951	hsa-miR-1307-3p	3.95	0.000104	0.2	0.26	Migraine;	chr10:103367830	chr10:103394301~103394322:-
CESC	cis	rs4988958	0.565	rs6732138	MIMAT0019927	hsa-miR-4772-3p	-3.95	0.000105	-0.25	-0.26	Asthma (childhood onset);	chr2:102393202	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.507	rs6543133	MIMAT0019927	hsa-miR-4772-3p	-3.95	0.000106	-0.25	-0.26	Asthma;	chr2:102423717	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.524	rs2110662	MIMAT0019927	hsa-miR-4772-3p	-3.95	0.000106	-0.25	-0.26	Asthma;	chr2:102403679	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.524	rs7594402	MIMAT0019927	hsa-miR-4772-3p	-3.95	0.000106	-0.25	-0.26	Asthma;	chr2:102404807	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.507	rs6710034	MIMAT0019927	hsa-miR-4772-3p	-3.95	0.000106	-0.25	-0.26	Asthma;	chr2:102407218	chr2:102432336~102432357:+
CESC	cis	rs4988958	0.584	rs7589142	MIMAT0019927	hsa-miR-4772-3p	-3.95	0.000106	-0.25	-0.26	Asthma (childhood onset);	chr2:102408200	chr2:102432336~102432357:+
CESC	cis	rs10021731	0.718	rs12505597	MIMAT0003242	hsa-miR-577	-3.94	0.000109	-0.27	-0.26	Optic disc area;	chr4:114527954	chr4:114656774~114656794:+
CESC	cis	rs56804039	0.524	rs11783173	MIMAT0019728	hsa-miR-4660	-3.94	0.000109	-0.36	-0.26	Cervical cancer;	chr8:8505200	chr8:9048453~9048475:+
CESC	cis	rs1867631	1	rs6665859	MIMAT0014979	hsa-miR-3117-3p	-3.94	0.000109	-0.32	-0.26	Menopause (age at onset);	chr1:66611872	chr1:66628485~66628505:+
CESC	cis	rs9807989	0.507	rs10439410	MIMAT0019927	hsa-miR-4772-3p	3.94	0.000109	0.25	0.26	Asthma;	chr2:102374328	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.507	rs6745614	MIMAT0019927	hsa-miR-4772-3p	-3.94	0.00011	-0.25	-0.26	Asthma;	chr2:102374753	chr2:102432336~102432357:+
CESC	cis	rs4841097	0.876	rs6601288	MIMAT0019728	hsa-miR-4660	3.94	0.00011	0.33	0.26	Platelet distribution width;	chr8:9085920	chr8:9048453~9048475:+
CESC	cis	rs4988958	0.565	rs12712146	MIMAT0019927	hsa-miR-4772-3p	-3.94	0.00011	-0.25	-0.26	Asthma (childhood onset);	chr2:102392254	chr2:102432336~102432357:+
CESC	cis	rs8026198	0.568	rs1659222	MIMAT0026623	hsa-miR-627-3p	3.94	0.000111	0.42	0.26	Fibrinogen levels;	chr15:42323071	chr15:42199593~42199612:-
CESC	cis	rs9814567	1	rs7619451	MIMAT0019958	hsa-miR-4788	3.94	0.000111	0.33	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134514396	chr3:134437836~134437857:+
CESC	cis	rs79387448	0.638	rs78123896	MIMAT0019926	hsa-miR-4772-5p	-3.93	0.000112	-0.43	-0.26	Gut microbiota (bacterial taxa);	chr2:102458957	chr2:102432300~102432321:+
CESC	cis	rs9807989	0.507	rs6734762	MIMAT0019927	hsa-miR-4772-3p	-3.93	0.000112	-0.25	-0.26	Asthma;	chr2:102446466	chr2:102432336~102432357:+
CESC	cis	rs2613514	0.614	rs67793638	MIMAT0030417	hsa-miR-6516-5p	3.93	0.000113	0.43	0.26	Thiazide-induced adverse metabolic effects in hypertensive patients;	chr17:78054457	chr17:77089428~77089449:+
CESC	cis	rs10021731	0.718	rs13102910	MIMAT0003242	hsa-miR-577	-3.93	0.000113	-0.27	-0.26	Optic disc area;	chr4:114493049	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs13127839	MIMAT0003242	hsa-miR-577	-3.93	0.000113	-0.27	-0.26	Optic disc area;	chr4:114493059	chr4:114656774~114656794:+
CESC	cis	rs7216064	0.953	rs62086043	MIMAT0003323	hsa-miR-548d-3p	3.93	0.000113	0.36	0.26	EGFR mutation-positive lung adenocarcinoma;Lung adenocarcinoma;Lung cancer;	chr17:67971887	chr17:67471504~67471525:-
CESC	cis	rs7216064	0.953	rs62086043	MIMAT0003323_1	hsa-miR-548d-3p	3.93	0.000113	0.36	0.26	EGFR mutation-positive lung adenocarcinoma;Lung adenocarcinoma;Lung cancer;	chr17:67971887	chr8:123348049~123348070:-
CESC	cis	rs10021731	0.718	rs13102706	MIMAT0003242	hsa-miR-577	-3.93	0.000114	-0.27	-0.26	Optic disc area;	chr4:114492998	chr4:114656774~114656794:+
CESC	cis	rs4988958	0.525	rs3771159	MIMAT0019927	hsa-miR-4772-3p	-3.93	0.000114	-0.25	-0.26	Asthma (childhood onset);	chr2:102388498	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.501	rs11903946	MIMAT0019927	hsa-miR-4772-3p	-3.93	0.000114	-0.25	-0.26	Asthma;	chr2:102388870	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.507	rs6706002	MIMAT0019927	hsa-miR-4772-3p	-3.93	0.000114	-0.25	-0.26	Asthma;	chr2:102389644	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.507	rs6749014	MIMAT0019927	hsa-miR-4772-3p	-3.93	0.000114	-0.25	-0.26	Asthma;	chr2:102389988	chr2:102432336~102432357:+
CESC	cis	rs79387448	0.638	rs74731686	MIMAT0019926	hsa-miR-4772-5p	-3.93	0.000114	-0.45	-0.26	Gut microbiota (bacterial taxa);	chr2:102427521	chr2:102432300~102432321:+
CESC	cis	rs75358501	0.636	rs12473690	MIMAT0014995	hsa-miR-3130-5p	3.93	0.000115	0.33	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783276~206783296:-
CESC	cis	rs75358501	0.636	rs12473690	MIMAT0014995_1	hsa-miR-3130-5p	3.93	0.000115	0.33	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783246~206783266:+
CESC	cis	rs7072216	0.763	rs10736129	MIMAT0005878	hsa-miR-1287-5p	-3.93	0.000115	-0.25	-0.26	Metabolite levels;	chr10:98411814	chr10:98395271~98395292:-
CESC	cis	rs10021731	0.83	rs4834421	MIMAT0003242	hsa-miR-577	3.93	0.000116	0.27	0.26	Optic disc area;	chr4:114572686	chr4:114656774~114656794:+
CESC	cis	rs79387448	0.638	rs6741230	MIMAT0019926	hsa-miR-4772-5p	-3.92	0.000116	-0.45	-0.26	Gut microbiota (bacterial taxa);	chr2:102453171	chr2:102432300~102432321:+
CESC	cis	rs79387448	0.638	rs7600961	MIMAT0019926	hsa-miR-4772-5p	-3.92	0.000117	-0.45	-0.26	Gut microbiota (bacterial taxa);	chr2:102418995	chr2:102432300~102432321:+
CESC	cis	rs9807989	0.839	rs1974675	MIMAT0019927	hsa-miR-4772-3p	-3.92	0.000118	-0.28	-0.26	Asthma;	chr2:102369915	chr2:102432336~102432357:+
CESC	cis	rs1472147	1	rs13225751	MIMAT0000095	hsa-miR-96-5p	3.92	0.000118	0.26	0.26	Calcium levels;	chr7:128864475	chr7:129774739~129774761:-
CESC	cis	rs1472147	1	rs13226115	MIMAT0000095	hsa-miR-96-5p	3.92	0.000118	0.26	0.26	Calcium levels;	chr7:128864521	chr7:129774739~129774761:-
CESC	cis	rs343496	0.877	rs340921	MIMAT0019739	hsa-miR-4665-5p	3.92	0.000118	0.4	0.26	Asthma and hay fever;	chr9:6090160	chr9:6007835~6007857:+
CESC	cis	rs9814567	0.964	rs9841180	MIMAT0019958	hsa-miR-4788	3.92	0.00012	0.31	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134473038	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.929	rs2241556	MIMAT0019958	hsa-miR-4788	-3.91	0.000121	-0.31	-0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134464470	chr3:134437836~134437857:+
CESC	cis	rs10021731	0.718	rs2219591	MIMAT0003242	hsa-miR-577	-3.91	0.000122	-0.27	-0.26	Optic disc area;	chr4:114491902	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs2199310	MIMAT0003242	hsa-miR-577	-3.91	0.000122	-0.27	-0.26	Optic disc area;	chr4:114492246	chr4:114656774~114656794:+
CESC	cis	rs9807989	0.839	rs3771166	MIMAT0019927	hsa-miR-4772-3p	-3.91	0.000123	-0.28	-0.26	Asthma;	chr2:102369762	chr2:102432336~102432357:+
CESC	cis	rs10021731	0.718	rs13103158	MIMAT0003242	hsa-miR-577	-3.91	0.000123	-0.27	-0.26	Optic disc area;	chr4:114493188	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.692	rs13127680	MIMAT0003242	hsa-miR-577	-3.91	0.000123	-0.27	-0.26	Optic disc area;	chr4:114493217	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.693	rs4834415	MIMAT0003242	hsa-miR-577	-3.91	0.000123	-0.27	-0.26	Optic disc area;	chr4:114493245	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs4833458	MIMAT0003242	hsa-miR-577	-3.91	0.000123	-0.27	-0.26	Optic disc area;	chr4:114493571	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs4833459	MIMAT0003242	hsa-miR-577	-3.91	0.000123	-0.27	-0.26	Optic disc area;	chr4:114493734	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs12501292	MIMAT0003242	hsa-miR-577	-3.91	0.000123	-0.27	-0.26	Optic disc area;	chr4:114493876	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.622	rs12711027	MIMAT0003242	hsa-miR-577	-3.91	0.000123	-0.27	-0.26	Optic disc area;	chr4:114494204	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs13148430	MIMAT0003242	hsa-miR-577	-3.91	0.000123	-0.27	-0.26	Optic disc area;	chr4:114494469	chr4:114656774~114656794:+
CESC	cis	rs453301	0.686	rs7017868	MIMAT0019728	hsa-miR-4660	-3.91	0.000124	-0.32	-0.26	Joint mobility (Beighton score);	chr8:9015783	chr8:9048453~9048475:+
CESC	cis	rs453301	0.686	rs3895823	MIMAT0019728	hsa-miR-4660	-3.91	0.000124	-0.32	-0.26	Joint mobility (Beighton score);	chr8:9016136	chr8:9048453~9048475:+
CESC	cis	rs10021731	0.718	rs13127822	MIMAT0003242	hsa-miR-577	-3.91	0.000126	-0.27	-0.26	Optic disc area;	chr4:114493024	chr4:114656774~114656794:+
CESC	cis	rs1472147	1	rs67476247	MIMAT0000095	hsa-miR-96-5p	3.9	0.000126	0.26	0.26	Calcium levels;	chr7:128864734	chr7:129774739~129774761:-
CESC	cis	rs9807989	0.507	rs6755905	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000127	-0.25	-0.26	Asthma;	chr2:102431747	chr2:102432336~102432357:+
CESC	cis	rs4988958	0.527	rs6756161	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000127	-0.25	-0.26	Asthma (childhood onset);	chr2:102431957	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.507	rs6726985	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000127	-0.25	-0.26	Asthma;	chr2:102432120	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.507	rs2310300	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000127	-0.25	-0.26	Asthma;	chr2:102432614	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.507	rs7581119	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000127	-0.25	-0.26	Asthma;	chr2:102433405	chr2:102432336~102432357:+
CESC	cis	rs7072216	0.652	rs11189600	MIMAT0005878	hsa-miR-1287-5p	-3.9	0.000127	-0.23	-0.26	Metabolite levels;	chr10:98419517	chr10:98395271~98395292:-
CESC	cis	rs6841433	0.706	rs13147491	MIMAT0003242	hsa-miR-577	3.9	0.000128	0.41	0.26	Hemoglobin concentration;	chr4:114696462	chr4:114656774~114656794:+
CESC	cis	rs9814567	1	rs3846055	MIMAT0019958	hsa-miR-4788	3.9	0.00013	0.32	0.26	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134485131	chr3:134437836~134437857:+
CESC	cis	rs9807989	0.839	rs1362348	MIMAT0019927	hsa-miR-4772-3p	-3.89	0.000131	-0.29	-0.26	Asthma;	chr2:102368164	chr2:102432336~102432357:+
CESC	cis	rs8026198	0.568	rs58712247	MIMAT0026623	hsa-miR-627-3p	3.89	0.000131	0.45	0.26	Fibrinogen levels;	chr15:42324090	chr15:42199593~42199612:-
CESC	cis	rs9807989	0.708	rs6543124	MIMAT0019927	hsa-miR-4772-3p	-3.89	0.000132	-0.28	-0.25	Asthma;	chr2:102370999	chr2:102432336~102432357:+
CESC	cis	rs10021731	0.718	rs7671026	MIMAT0003242	hsa-miR-577	-3.89	0.000132	-0.27	-0.25	Optic disc area;	chr4:114487736	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.692	rs10031142	MIMAT0003242	hsa-miR-577	-3.89	0.000132	-0.27	-0.25	Optic disc area;	chr4:114488433	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs17678686	MIMAT0003242	hsa-miR-577	-3.89	0.000132	-0.27	-0.25	Optic disc area;	chr4:114489100	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs28766989	MIMAT0003242	hsa-miR-577	-3.89	0.000132	-0.27	-0.25	Optic disc area;	chr4:114489752	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.692	rs11722125	MIMAT0003242	hsa-miR-577	-3.89	0.000132	-0.27	-0.25	Optic disc area;	chr4:114490374	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.692	rs11722162	MIMAT0003242	hsa-miR-577	-3.89	0.000132	-0.27	-0.25	Optic disc area;	chr4:114490460	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.668	rs11722201	MIMAT0003242	hsa-miR-577	-3.89	0.000132	-0.27	-0.25	Optic disc area;	chr4:114490577	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.692	rs1585448	MIMAT0003242	hsa-miR-577	-3.89	0.000132	-0.27	-0.25	Optic disc area;	chr4:114491050	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs1870655	MIMAT0003242	hsa-miR-577	-3.89	0.000132	-0.27	-0.25	Optic disc area;	chr4:114491625	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs10028232	MIMAT0003242	hsa-miR-577	-3.89	0.000133	-0.27	-0.25	Optic disc area;	chr4:114487644	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs1460771	MIMAT0003242	hsa-miR-577	3.89	0.000133	0.27	0.25	Optic disc area;	chr4:114486755	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.798	rs34581144	MIMAT0003242	hsa-miR-577	3.89	0.000133	0.27	0.25	Optic disc area;	chr4:114583571	chr4:114656774~114656794:+
CESC	cis	rs1712517	0.771	rs2008530	MIMAT0005951	hsa-miR-1307-3p	-3.89	0.000133	-0.2	-0.25	Migraine;	chr10:103299082	chr10:103394301~103394322:-
CESC	cis	rs10021731	0.668	rs2199311	MIMAT0003242	hsa-miR-577	-3.89	0.000134	-0.27	-0.25	Optic disc area;	chr4:114492288	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs10857031	MIMAT0003242	hsa-miR-577	-3.89	0.000134	-0.26	-0.25	Optic disc area;	chr4:114527690	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.645	rs7698524	MIMAT0003242	hsa-miR-577	-3.89	0.000135	-0.27	-0.25	Optic disc area;	chr4:114492417	chr4:114656774~114656794:+
CESC	cis	rs8064299	0.967	rs3744208	MIMAT0017994	hsa-miR-3615	-3.88	0.000137	-0.25	-0.25	Monocyte count;	chr17:74771426	chr17:74748663~74748683:+
CESC	cis	rs3087591	1	rs2905877	MIMAT0022834	hsa-miR-365b-3p	3.88	0.000137	0.24	0.25	Hip circumference;	chr17:31216251	chr17:31575478~31575499:+
CESC	cis	rs10021731	0.718	rs1460779	MIMAT0003242	hsa-miR-577	3.88	0.000138	0.27	0.25	Optic disc area;	chr4:114528894	chr4:114656774~114656794:+
CESC	cis	rs11186	0.556	rs13421823	MIMAT0022706	hsa-miR-561-5p	3.88	0.000138	0.39	0.25	Parkinson's disease;	chr2:189074234	chr2:188297517~188297538:+
CESC	cis	rs7216064	0.953	rs10445361	MIMAT0003323	hsa-miR-548d-3p	-3.88	0.00014	-0.35	-0.25	EGFR mutation-positive lung adenocarcinoma;Lung adenocarcinoma;Lung cancer;	chr17:67966122	chr17:67471504~67471525:-
CESC	cis	rs7216064	0.953	rs10445361	MIMAT0003323_1	hsa-miR-548d-3p	-3.88	0.00014	-0.35	-0.25	EGFR mutation-positive lung adenocarcinoma;Lung adenocarcinoma;Lung cancer;	chr17:67966122	chr8:123348049~123348070:-
CESC	cis	rs453301	0.658	rs6986044	MIMAT0019728	hsa-miR-4660	-3.88	0.000141	-0.31	-0.25	Joint mobility (Beighton score);	chr8:9017276	chr8:9048453~9048475:+
CESC	cis	rs9807989	0.839	rs13392100	MIMAT0019927	hsa-miR-4772-3p	-3.87	0.000142	-0.28	-0.25	Asthma;	chr2:102365634	chr2:102432336~102432357:+
CESC	cis	rs950880	0.542	rs6543118	MIMAT0019927	hsa-miR-4772-3p	3.87	0.000143	0.23	0.25	Serum protein levels (sST2);	chr2:102313009	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.507	rs3755266	MIMAT0019927	hsa-miR-4772-3p	-3.87	0.000143	-0.25	-0.25	Asthma;	chr2:102426252	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.507	rs2110659	MIMAT0019927	hsa-miR-4772-3p	-3.87	0.000143	-0.25	-0.25	Asthma;	chr2:102427407	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.507	rs7605284	MIMAT0019927	hsa-miR-4772-3p	-3.87	0.000143	-0.25	-0.25	Asthma;	chr2:102427715	chr2:102432336~102432357:+
CESC	cis	rs4988958	0.584	rs12712149	MIMAT0019927	hsa-miR-4772-3p	-3.87	0.000143	-0.25	-0.25	Asthma (childhood onset);	chr2:102428733	chr2:102432336~102432357:+
CESC	cis	rs4988958	0.584	rs7559845	MIMAT0019927	hsa-miR-4772-3p	-3.87	0.000143	-0.25	-0.25	Asthma (childhood onset);	chr2:102429754	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.507	rs1420094	MIMAT0019927	hsa-miR-4772-3p	-3.87	0.000144	-0.25	-0.25	Asthma;	chr2:102399227	chr2:102432336~102432357:+
CESC	cis	rs10021731	0.692	rs1599316	MIMAT0003242	hsa-miR-577	-3.87	0.000145	-0.27	-0.25	Optic disc area;	chr4:114490702	chr4:114656774~114656794:+
CESC	cis	rs10021731	0.718	rs1585446	MIMAT0003242	hsa-miR-577	-3.87	0.000145	-0.27	-0.25	Optic disc area;	chr4:114490871	chr4:114656774~114656794:+
CESC	cis	rs8026198	0.568	rs4924672	MIMAT0026623	hsa-miR-627-3p	3.87	0.000147	0.49	0.25	Fibrinogen levels;	chr15:42329581	chr15:42199593~42199612:-
CESC	cis	rs9807989	0.839	rs10182710	MIMAT0019927	hsa-miR-4772-3p	-3.86	0.000147	-0.28	-0.25	Asthma;	chr2:102364846	chr2:102432336~102432357:+
CESC	cis	rs1163656	0.534	rs17007709	MIMAT0003287	hsa-miR-618	-3.86	0.000147	-0.36	-0.25	Dental caries;	chr12:80934267	chr12:80935796~80935818:-
CESC	cis	rs7649443	0.959	rs2341225	MIMAT0019973	hsa-miR-4797-3p	3.86	0.000148	0.31	0.25	Nonsyndromic cleft lip with cleft palate;	chr3:197098527	chr3:197293888~197293908:-
CESC	cis	rs9807989	0.801	rs11123925	MIMAT0019927	hsa-miR-4772-3p	-3.86	0.000149	-0.27	-0.25	Asthma;	chr2:102361051	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.839	rs10204837	MIMAT0019927	hsa-miR-4772-3p	-3.86	0.000149	-0.27	-0.25	Asthma;	chr2:102361270	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.839	rs3755276	MIMAT0019927	hsa-miR-4772-3p	-3.86	0.000149	-0.27	-0.25	Asthma;	chr2:102361999	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.839	rs9308857	MIMAT0019927	hsa-miR-4772-3p	-3.86	0.000149	-0.27	-0.25	Asthma;	chr2:102363164	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.839	rs1420099	MIMAT0019927	hsa-miR-4772-3p	-3.86	0.000149	-0.27	-0.25	Asthma;	chr2:102364083	chr2:102432336~102432357:+
CESC	cis	rs950880	0.56	rs10178436	MIMAT0019927	hsa-miR-4772-3p	3.86	0.000149	0.23	0.25	Serum protein levels (sST2);	chr2:102310051	chr2:102432336~102432357:+
CESC	cis	rs950880	0.56	rs11679191	MIMAT0019927	hsa-miR-4772-3p	3.86	0.000151	0.23	0.25	Serum protein levels (sST2);	chr2:102310340	chr2:102432336~102432357:+
CESC	cis	rs950880	0.56	rs11685424	MIMAT0019927	hsa-miR-4772-3p	3.86	0.000151	0.23	0.25	Serum protein levels (sST2);	chr2:102310521	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.801	rs10173193	MIMAT0019927	hsa-miR-4772-3p	-3.86	0.000151	-0.27	-0.25	Asthma;	chr2:102358590	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.801	rs10176664	MIMAT0019927	hsa-miR-4772-3p	-3.86	0.000151	-0.27	-0.25	Asthma;	chr2:102359712	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.839	rs6543123	MIMAT0019927	hsa-miR-4772-3p	-3.86	0.000151	-0.27	-0.25	Asthma;	chr2:102360736	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.507	rs10200952	MIMAT0019927	hsa-miR-4772-3p	-3.86	0.000151	-0.24	-0.25	Asthma;	chr2:102411191	chr2:102432336~102432357:+
CESC	cis	rs11186	0.556	rs13383261	MIMAT0022706	hsa-miR-561-5p	3.86	0.000152	0.39	0.25	Parkinson's disease;	chr2:189049022	chr2:188297517~188297538:+
CESC	cis	rs10021731	0.718	rs13104081	MIMAT0003242	hsa-miR-577	-3.85	0.000152	-0.26	-0.25	Optic disc area;	chr4:114532641	chr4:114656774~114656794:+
CESC	cis	rs9814567	0.806	rs4519744	MIMAT0019958	hsa-miR-4788	3.85	0.000153	0.32	0.25	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134602681	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.806	rs4245904	MIMAT0019958	hsa-miR-4788	3.85	0.000153	0.32	0.25	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134602966	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.806	rs1880374	MIMAT0019958	hsa-miR-4788	3.85	0.000153	0.32	0.25	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134603271	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.806	rs1880375	MIMAT0019958	hsa-miR-4788	3.85	0.000153	0.32	0.25	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134603321	chr3:134437836~134437857:+
CESC	cis	rs9807989	0.507	rs10203558	MIMAT0019927	hsa-miR-4772-3p	-3.85	0.000153	-0.24	-0.25	Asthma;	chr2:102411180	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.507	rs1420096	MIMAT0019927	hsa-miR-4772-3p	-3.85	0.000154	-0.24	-0.25	Asthma;	chr2:102394452	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.507	rs4851571	MIMAT0019927	hsa-miR-4772-3p	-3.85	0.000155	-0.24	-0.25	Asthma;	chr2:102402540	chr2:102432336~102432357:+
CESC	cis	rs9807989	0.507	rs4851572	MIMAT0019927	hsa-miR-4772-3p	-3.85	0.000155	-0.24	-0.25	Asthma;	chr2:102402571	chr2:102432336~102432357:+
CESC	cis	rs9814567	0.806	rs4955534	MIMAT0019958	hsa-miR-4788	3.85	0.000155	0.32	0.25	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134600881	chr3:134437836~134437857:+
CESC	cis	rs9814567	0.806	rs9841371	MIMAT0019958	hsa-miR-4788	3.85	0.000155	0.32	0.25	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134601923	chr3:134437836~134437857:+
CESC	cis	rs9807989	0.507	rs1035129	MIMAT0019927	hsa-miR-4772-3p	-3.85	0.000156	-0.24	-0.25	Asthma;	chr2:102403325	chr2:102432336~102432357:+
CESC	cis	rs7649443	0.959	rs6782621	MIMAT0019973	hsa-miR-4797-3p	3.85	0.000157	0.3	0.25	Nonsyndromic cleft lip with cleft palate;	chr3:197112157	chr3:197293888~197293908:-
CESC	cis	rs7649443	0.921	rs12631361	MIMAT0019973	hsa-miR-4797-3p	3.85	0.000157	0.3	0.25	Nonsyndromic cleft lip with cleft palate;	chr3:197114703	chr3:197293888~197293908:-
CESC	trans	rs4566357	0.576	rs3769644	MIMAT0001639	hsa-miR-409-3p	6.07	5.51e-09	0.18	0.38	Coronary artery disease;	chr2:227052524	chr14:101065346~101065367:+
CESC	trans	rs4566357	0.615	rs3769643	MIMAT0001639	hsa-miR-409-3p	6.07	5.51e-09	0.18	0.38	Coronary artery disease;	chr2:227052554	chr14:101065346~101065367:+
CESC	trans	rs4566357	0.615	rs3769642	MIMAT0001639	hsa-miR-409-3p	6.07	5.51e-09	0.18	0.38	Coronary artery disease;	chr2:227052607	chr14:101065346~101065367:+
CESC	trans	rs4566357	0.615	rs4350744	MIMAT0001639	hsa-miR-409-3p	6.07	5.51e-09	0.18	0.38	Coronary artery disease;	chr2:227053430	chr14:101065346~101065367:+
CESC	trans	rs4566357	0.615	rs2894626	MIMAT0001639	hsa-miR-409-3p	6.03	7.05e-09	0.17	0.38	Coronary artery disease;	chr2:227051323	chr14:101065346~101065367:+
CESC	trans	rs4566357	0.615	rs10184991	MIMAT0001639	hsa-miR-409-3p	6.01	7.72e-09	0.18	0.38	Coronary artery disease;	chr2:227051817	chr14:101065346~101065367:+
CESC	trans	rs889312	0.781	rs6450402	MIMAT0003338	hsa-miR-660-5p	6.01	7.91e-09	0.29	0.38	Breast cancer (early onset);Breast cancer;	chr5:56744563	chrX:50013256~50013277:+
CESC	trans	rs4566357	0.615	rs10178098	MIMAT0001639	hsa-miR-409-3p	5.86	1.72e-08	0.17	0.37	Coronary artery disease;	chr2:227049709	chr14:101065346~101065367:+
CESC	trans	rs4566357	0.595	rs10201538	MIMAT0001639	hsa-miR-409-3p	5.86	1.72e-08	0.17	0.37	Coronary artery disease;	chr2:227049733	chr14:101065346~101065367:+
CESC	trans	rs4566357	0.615	rs10178260	MIMAT0001639	hsa-miR-409-3p	5.86	1.72e-08	0.17	0.37	Coronary artery disease;	chr2:227049742	chr14:101065346~101065367:+
CESC	trans	rs9857275	0.501	rs11707656	MIMAT0026557	hsa-miR-412-5p	-5.84	1.9e-08	-0.47	-0.37	Prion diseases;	chr3:141568368	chr14:101065465~101065487:+
CESC	trans	rs4566357	0.557	rs2272201	MIMAT0001639	hsa-miR-409-3p	5.83	1.93e-08	0.17	0.37	Coronary artery disease;	chr2:227047835	chr14:101065346~101065367:+
CESC	trans	rs4566357	0.615	rs12474622	MIMAT0001639	hsa-miR-409-3p	5.83	1.93e-08	0.17	0.37	Coronary artery disease;	chr2:227048077	chr14:101065346~101065367:+
CESC	trans	rs4566357	0.615	rs10174591	MIMAT0001639	hsa-miR-409-3p	5.83	1.93e-08	0.17	0.37	Coronary artery disease;	chr2:227048424	chr14:101065346~101065367:+
CESC	trans	rs4566357	0.576	rs10187255	MIMAT0001639	hsa-miR-409-3p	5.83	1.93e-08	0.17	0.37	Coronary artery disease;	chr2:227048726	chr14:101065346~101065367:+
CESC	trans	rs4566357	0.615	rs10177528	MIMAT0001639	hsa-miR-409-3p	5.83	1.93e-08	0.17	0.37	Coronary artery disease;	chr2:227048990	chr14:101065346~101065367:+